<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Oral Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">J Oral Microbiol</journal-id><journal-title-group><journal-title>Journal of Oral Microbiology</journal-title></journal-title-group><issn pub-type="epub">2000-2297</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013013</article-id><article-id pub-id-type="pmc">PMC11864007</article-id><article-id pub-id-type="doi">10.1080/20002297.2025.2469896</article-id><article-id pub-id-type="publisher-id">2469896</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Polymicrobial interactions of <italic toggle="yes">Helicobacter pylori</italic> and its role in the process of oral diseases</article-title><alt-title alt-title-type="left-running-head">Y. FAN ET AL.</alt-title><alt-title alt-title-type="right-running-head">JOURNAL OF ORAL MICROBIOLOGY</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Yufei</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="an0003" ref-type="author-notes">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xi</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="an0003" ref-type="author-notes">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shan</surname><given-names>Tiantian</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Nanxi</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Qi</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ren</surname><given-names>Biao</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2762-4740</contrib-id><name><surname>Cheng</surname><given-names>Lei</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>b</sup>
</xref><xref rid="an0002" ref-type="corresp"/></contrib><aff id="aff0001"><label>a</label>State Key Laboratory of Oral Diseases &#x00026; National Center for Stomatology &#x00026; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, <institution-wrap><institution>Sichuan University</institution></institution-wrap>, <city>Chengdu</city>, <country>China</country></aff><aff id="aff0002"><label>b</label>Department of Operative Dentistry and Endodontics, West China Hospital of Stomatology, <institution-wrap><institution>Sichuan University</institution></institution-wrap>, <city>Chengdu</city>, <country>China</country></aff><aff id="aff0003"><label>c</label>Department of Oral Pathology, West China Hospital of Stomatology, <institution-wrap><institution>Sichuan University</institution></institution-wrap>, <city>Chengdu</city>, <country>China</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT Biao Ren <email xlink:href="mailto:renbiao@scu.edu.cn">renbiao@scu.edu.cn</email></corresp><corresp id="an0002">Lei Cheng <email xlink:href="mailto:chenglei@scu.edu.cn">chenglei@scu.edu.cn</email> State Key Laboratory of Oral Diseases &#x00026; National Center for Stomatology &#x00026; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, No. 14, Section 3, Renmin South Road, Chengdu <postal-code>610041</postal-code>, <country>China</country></corresp><fn id="an0003"><label>*</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>1</issue><elocation-id seq="18">2469896</elocation-id><pub-history><event event-type="tagger"><event-desc>Integra</event-desc><date><day>25</day><month>2</month><year>2025</year></date></event><event event-type="final"><event-desc>Integra</event-desc><date><day>25</day><month>2</month><year>2025</year></date></event><event event-type="received"><date><day>12</day><month>10</month><year>2024</year></date></event><event event-type="revised"><date><day>12</day><month>1</month><year>2025</year></date></event><event event-type="accepted"><date><day>14</day><month>2</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#x000a9; 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ZJOM_17_2469896.pdf"/><abstract><title>ABSTRACT</title><sec><title>Objective</title><p><italic toggle="yes">Helicobacter pylori (H.&#x000a0;pylori)</italic>&#x000a0;infection affects approximately 50% of the global population. The predominant route of <italic toggle="yes">H. pylori</italic> transmission is through the oral pathway, making the oral cavity highly significant in its infection.&#x000a0;This review focuses on the relationship between <italic toggle="yes">H.&#x000a0;pylori</italic>&#x000a0;and oral diseases, the influence of <italic toggle="yes">H.&#x000a0;pylori</italic>&#x000a0;infection on the oral microbiota, and the potential mechanisms involving certain oral pathogens.</p></sec><sec><title>Method</title><p>To identify relevant studies, we conducted searches in PubMed, Google Scholar using keywords such as &#x0201c;<italic toggle="yes">Helicobacter pylori</italic>,&#x0201d; &#x0201c;oral diseases, &#x0201d; &#x0201c;oral microorganisms, &#x0201d; without any date restrictions. The retrieved publications were subject to a review.</p></sec><sec><title>Results</title><p><italic toggle="yes">H.&#x000a0;pylori</italic>&#x000a0;infection is positively correlated with the occurrence of various oral diseases, such as dental caries, periodontitis, and oral lichen planus. <italic toggle="yes">H.&#x000a0;pylori</italic>&#x000a0;may affect the oral microbiota through various mechanisms, and there exists an interactive relationship between <italic toggle="yes">H.&#x000a0;pylori</italic>&#x000a0;and oral bacteria, including <italic toggle="yes">Streptococcus</italic>, <italic toggle="yes">Porphyromonas gingivalis (P. gingivalis)</italic>, and <italic toggle="yes">Candida albicans (C. albicans)</italic>.</p></sec><sec><title>Conclusions</title><p><italic toggle="yes">H.&#x000a0;pylori</italic>&#x000a0;infection has a close relationship with certain oral diseases. <italic toggle="yes">H.</italic>&#x000a0;<italic toggle="yes">pylori</italic> modulates oral microflora diversity and structure, while eradication therapy and medications have varying impacts on oral microbiota.</p></sec></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd><italic toggle="yes">Helicobacter pylori</italic></kwd><kwd>oral diseases</kwd><kwd>oral microbiology</kwd><kwd>interaction</kwd><kwd>eradication therapy</kwd></kwd-group><support-group><funding-group><award-group><funding-source>
<institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100001809</institution-id></institution-wrap>
</funding-source><award-id>82271033</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>Postdoctoral Fellowship Program of China Postdoctoral Science Foundation</institution></institution-wrap>
</funding-source><award-id>GZC20241122</award-id></award-group><funding-statement>This work was supported by the National Natural Science Foundation of China under Grant [82271033] (L.C.); and the Postdoctoral Fellowship Program of China Postdoctoral Science Foundation under Grant [GZC20241122] (X.C.).</funding-statement></funding-group></support-group><counts><fig-count count="2"/><table-count count="1"/><ref-count count="132"/><page-count count="1"/><word-count count="7851"/></counts></article-meta></front><body><sec sec-type="intro" disp-level="1" id="s0001"><title>Introduction</title><p><italic toggle="yes">Helicobacter pylori</italic>, a gram-negative bacterium, is estimated to have infected approximately 50% of the global population [<xref rid="cit0001" ref-type="bibr">1</xref>]. It is recognized as a pathogen causing gastric-related diseases, including chronic atrophic gastritis, superficial gastritis, and peptic and duodenal ulcers [<xref rid="cit0002" ref-type="bibr">2</xref>]. Based on the close association between <italic toggle="yes">H. pylori</italic> and gastric adenocarcinoma, the International Agency for Research on Cancer has designated <italic toggle="yes">H. pylori</italic> as a Group 1 carcinogen [<xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0004" ref-type="bibr">4</xref>]. Additionally, it has been linked to extra-gastrointestinal diseases, such as iron deficiency anemia idiopathic thrombocytopenic purpura [<xref rid="cit0002" ref-type="bibr">2</xref>], and Alzheimer&#x02019;s disease [<xref rid="cit0005" ref-type="bibr">5</xref>], posing great risks to human health. In addition, numerous reports have revealed subtle connections between <italic toggle="yes">H. pylori</italic> and oral diseases, such as dental caries [<xref rid="cit0006" ref-type="bibr">6</xref>], periodontitis [<xref rid="cit0007" ref-type="bibr">7</xref>], oral lichen planus (OLP) [<xref rid="cit0008" ref-type="bibr">8</xref>], and oral squamous cell carcinoma (OSCC) [<xref rid="cit0009" ref-type="bibr">9</xref>], and it may influence the onset and progression of diseases through a variety of mechanisms.</p><p>The oral cavity harbors the second largest and most highly diverse community of microorganisms only after the gut [<xref rid="cit0010" ref-type="bibr">10</xref>]. The oral and gastric environments are influenced by saliva and digested food, with the oral microbiome serving as a primary source of the gastric microbiota [<xref rid="cit0011" ref-type="bibr">11</xref>]. Among all possible transmission routes, the oral pathway, including oral-oral and fecal-oral, is considered the main transmission route for <italic toggle="yes">H. pylori</italic> [<xref rid="cit0012" ref-type="bibr">12</xref>]. <italic toggle="yes">H. pylori</italic> DNA or specific antigens can be detected in various oral samples, such as saliva, dental plaque [<xref rid="cit0013" ref-type="bibr">13</xref>], dentine of deep caries [<xref rid="cit0014" ref-type="bibr">14</xref>], and inflamed pulp [<xref rid="cit0015" ref-type="bibr">15</xref>,<xref rid="cit0016" ref-type="bibr">16</xref>]. Although the amount of <italic toggle="yes">H. pylori</italic> in the oral cavity is much lower than that in the stomach, oral cavity may serves as a reservoir of <italic toggle="yes">H. pylori</italic> that can result in the higher risk of gastric reinfections [<xref rid="cit0017" ref-type="bibr">17</xref>].</p><p>The oral-gut axis microbiota plays a dominant role in the colonization, infection, and pathogenicity of <italic toggle="yes">H. pylori</italic> [<xref rid="cit0011" ref-type="bibr">11</xref>]. These bacterial communities engage in metabolic and material exchanges within the microenvironment, maintaining oral microbial balance, which is crucial for oral and systemic health. The presence of <italic toggle="yes">H. pylori</italic> in the oral cavity impacts its composition and posing potential risks to the resident oral flora. This interaction may not only impact the onset and progression of oral diseases but also hinder the successful elimination of gastric <italic toggle="yes">H. pylori</italic> infections.</p><p>This review focuses on the <italic toggle="yes">H. pylori</italic> and oral diseases, as well as its interactions with the oral microbiota. It aims to elucidate the current relationship between <italic toggle="yes">H. pylori</italic> infection and oral diseases, the impact of <italic toggle="yes">H. pylori</italic> on the oral microbiome, the interactions between <italic toggle="yes">H. pylori</italic> and specific oral microorganisms, and the eradication therapy of <italic toggle="yes">H. pylori</italic> along with the potential mechanisms. This provides new insights and perspectives for the prevention and treatment of <italic toggle="yes">H. pylori</italic>.</p></sec><sec disp-level="1" id="s0002"><title>H. pylori and oral diseases</title><sec disp-level="2" id="s0002-s2001"><title>Dental caries</title><p>Caries is a pathological condition that can lead to the degradation of the dental hard tissues, which is thought to be primarily due to the action of cariogenic bacteria in the biofilms that adhering to the enamel surface [<xref rid="cit0018" ref-type="bibr">18</xref>]. In a cross-section study, 11% (81/752) subjects were identified as gastric <italic toggle="yes">H. pylori</italic> infection by blood antibody testing or pepsinogen testing. After adjusting for age, gender, gastric disease, and other factors, a positive association of <italic toggle="yes">H. pylori</italic> and caries was established (OR, 5.656; 95% CI, 3.374 to 9.479) [<xref rid="cit0006" ref-type="bibr">6</xref>]. Higher levels of <italic toggle="yes">H. pylori</italic> infection in the bloodstream are associated with an increased quantity of decayed teeth. By quantitative reverse transcriptase polymerase chain reaction (RT-PCR), <italic toggle="yes">H. pylori</italic> was detected in 70% of children with severe carious lesions (95% confidence interval: 46%-88%) [<xref rid="cit0019" ref-type="bibr">19</xref>]. Oral <italic toggle="yes">H. pylori</italic> infection correlates with increased decayed, missing, filled teeth, as well as higher decayed teeth scores, and elevated scores on the International Caries Detection and Assessment System II were associated with a higher incidence of oral <italic toggle="yes">H. pylori</italic> positivity [<xref rid="cit0019" ref-type="bibr">19</xref>]. Another study also revealed the significant correlation between <italic toggle="yes">H. pylori</italic> infection and dental caries. By nested polymerase chain reaction (nested PCR), among 126 <italic toggle="yes">H. pylori</italic>-positive children, 70 (55.6%) are with dental caries, while 36 (40.9%) who were without <italic toggle="yes">H. pylori</italic> infection had dental caries, with an odds ratio of 1.806 (&#x003c7;<sup>2</sup>&#x02009;=&#x02009;4.446, <italic toggle="yes">p</italic>&#x02009;=0&#x02009;.035) [<xref rid="cit0020" ref-type="bibr">20</xref>]. Studies demonstrated that the prevalence of oral <italic toggle="yes">H. pylori</italic> (by salivary flagellin and urease antigen test), was notably higher among individuals (66.91%) with caries, comparing to (54.07%) those orally healthy individuals [<xref rid="cit0021" ref-type="bibr">21</xref>]. Studies also found that the incidence of dental caries is positively correlated with the failure rate of <italic toggle="yes">H. pylori</italic> eradication, and there is also a positive correlation with the number of dental caries [<xref rid="cit0022" ref-type="bibr">22</xref>]. The compromised blood circulation in carious dental tissue may hinder the penetration of antimicrobial drugs, contributing to the challenges in eradicating oral <italic toggle="yes">H. pylori</italic> [<xref rid="cit0022" ref-type="bibr">22</xref>]. However, all research failed to elucidate the mechanism of the relationship between <italic toggle="yes">H. pylori</italic> and caries.</p></sec><sec disp-level="2" id="s0002-s2002"><title>Periodontitis</title><p>Periodontitis, characterized by the alveolar bone loss and destruction of periodontal tissues, arises from the sophisticated and dynamic interplay between specific pathogens, such as <italic toggle="yes">P. gingivalis</italic>, and destructive immune responses [<xref rid="cit0023" ref-type="bibr">23</xref>]. Increasing number of studies examined the association between <italic toggle="yes">H. pylori</italic> and periodontitis in recent years. A meta-analysis combining 8 cross-sectional studies and 15 case-control studies showed that the odds ratio of <italic toggle="yes">H. pylori</italic> infection in periodontitis patients was 2.47 [<xref rid="cit0024" ref-type="bibr">24</xref>]. Another meta-analysis indicated a <italic toggle="yes">H. pylori</italic>-positive state increased the risk of chronic periodontitis 3.42 times [<xref rid="cit0007" ref-type="bibr">7</xref>]. It was shown that there was a positive and significant association between these two variables. The possible mechanisms underlying were: (1) periodontal tissue destruction due to <italic toggle="yes">H. pylori</italic> infection by raising the level of inflammation in periodontal tissues; (2) strains with different virulence levels cause varying degrees of destruction to periodontal tissues.</p><p><italic toggle="yes">H. pylori</italic> increased the expression levels of inflammatory factors in tissues, such as interleukin (IL) &#x02212;17, which promotes the destruction of periodontal tissues. Research has indicated that in patients with periodontitis, there is a decrease in methylation of the IL-17C promoter region, leading to its increased expression [<xref rid="cit0025" ref-type="bibr">25</xref>]. IL-17C is a member of the IL 17 family. IL-17 contributes to periodontal bone resorption by influencing the expression of RANKL and osteoprotegerin [<xref rid="cit0026" ref-type="bibr">26</xref>]. The expression of IL-17 was augmented in gastric mucosa by the colonization of <italic toggle="yes">H. pylori</italic> [<xref rid="cit0027" ref-type="bibr">27</xref>]. <italic toggle="yes">H. pylori</italic> may play a role in the destructive process within periodontal tissues by enhancing the expression of IL-17.</p><p>The vacuolating cytotoxin (VacA) and the cytotoxin-associated protein A (CagA), two major virulence factors of <italic toggle="yes">H. pylori</italic>, are key determinants of the bacterial pathogenicity. The sequence of <italic toggle="yes">vacA</italic> displays a sophisticated allelic architecture, based on which the <italic toggle="yes">vacA</italic> can be subclassified into four subtypes, s1m1, s1m2, s2m1, and s2m2, which exhibits a strong correlation with the pathogenicity of <italic toggle="yes">H. pylori</italic> [<xref rid="cit0028" ref-type="bibr">28</xref>]. A study indicated that the presence of periodontitis was linked to both the prevalence and the specific genetic strains of <italic toggle="yes">H. pylori</italic> in subgingival plaque. Specifically, notable disparities emerged in the oral <italic toggle="yes">H. pylori</italic> between patients with early and advanced periodontitis. Notably, the highest <italic toggle="yes">H. pylori</italic> detection rate was in stage III/IV periodontitis. The genotype <italic toggle="yes">cagA</italic>/<italic toggle="yes">vacAs1m2</italic> was predominantly identified in individuals with periodontitis at stage I/II, while the genotype <italic toggle="yes">cagA</italic>/<italic toggle="yes">vacAs1m1</italic> are primarily found in stage III/IV [<xref rid="cit0029" ref-type="bibr">29</xref>]. Another study found among those <italic toggle="yes">H. pylori</italic>-positive, the <italic toggle="yes">vacA</italic> gene was identified in all <italic toggle="yes">H. pylori</italic>-positive patients, while the <italic toggle="yes">cagA</italic> gene detection rate was 21.7% in <italic toggle="yes">H. pylori</italic>-positive individuals. By employing periodontal examination, 40% of those with <italic toggle="yes">cagA</italic>-positivity subjects were classified as moderate to severe periodontitis [<xref rid="cit0030" ref-type="bibr">30</xref>]. Therefore, <italic toggle="yes">cagA</italic> and <italic toggle="yes">vacA</italic> can be regarded as indicators of the state of this oral disease.</p><p>Furthermore, periodontal treatment and Helicobacter pylori eradication can be mutually reinforcing. A study demonstrated that periodontal treatment, including quadrant scaling and root planning, combined with <italic toggle="yes">H. pylori</italic> sequence therapy, can more effectively improve periodontal clinical parameters [<xref rid="cit0031" ref-type="bibr">31</xref>]. In another study, compared with alone drug therapy alone, the combination of eradication therapy and periodontal treatment brought more benefits to patients with <italic toggle="yes">H. pylori</italic>-associated gastric diseases, and led to a decreased recurrence of gastric <italic toggle="yes">H. pylori</italic> [<xref rid="cit0032" ref-type="bibr">32</xref>,<xref rid="cit0033" ref-type="bibr">33</xref>]. <italic toggle="yes">H. pylori</italic> positive individuals accompanied by symptoms of dyspepsia, may benefit from periodontal treatment [<xref rid="cit0033" ref-type="bibr">33</xref>]. Furthermore, maintaining oral hygiene and eliminating oral <italic toggle="yes">H. pylori</italic> can prevent the development of periodontitis [<xref rid="cit0030" ref-type="bibr">30</xref>]. These results indicated the mutual benefits of the therapy in eradication of <italic toggle="yes">H. pylori</italic> and periodontal treatment.</p><p>Alzheimer&#x02019;s disease (AD) has been associated with <italic toggle="yes">H. pylori</italic> infection, and the relationship between periodontitis and AD has also been reported [<xref rid="cit0034" ref-type="bibr">34</xref>,<xref rid="cit0035" ref-type="bibr">35</xref>]. Lipopolysaccharides (LPS) produced by <italic toggle="yes">P. gingivalis</italic>, a pathogen related to periodontitis were detected in the brains of AD patients [<xref rid="cit0036" ref-type="bibr">36</xref>]. A recent study revealed the interconnections among periodontal pathogens, AD, and <italic toggle="yes">H. pylori</italic> infection. Co-infection of <italic toggle="yes">H. pylori</italic> and periodontal pathogens altered the incidence of AD and all-cause dementia. <italic toggle="yes">Prevotella intermedia</italic>, <italic toggle="yes">Campylobacter rectus</italic>, and factor 2 (<italic toggle="yes">Pi/Prevotella nigrescens/Prevotella melaninogenica</italic>), and the Orange-Red cluster demonstrated an interaction with <italic toggle="yes">H. pylori</italic> seropositivity. Elevated levels of <italic toggle="yes">Actinomyces naeslundii</italic> enhanced the impact of <italic toggle="yes">H. pylori</italic>-positive on AD and all-cause dementia [<xref rid="cit0005" ref-type="bibr">5</xref>]. AD represents an acquired, progressively declining cognitive condition that may ultimately result in brain atrophy and dementia [<xref rid="cit0037" ref-type="bibr">37</xref>]. The involvement of <italic toggle="yes">H. pylori</italic> in AD remains not fully understood. The possible mechanism may lies in: (1) The inflammatory mediators released by <italic toggle="yes">H. pylori</italic>-induced gastritis interfere with the transmission of neurotransmitters or directly disrupt the function of the blood-brain barrier [<xref rid="cit0038" ref-type="bibr">38</xref>]. <italic toggle="yes">H. pylori</italic>-related galectin-3 enhances microbe&#x02019;s role in areas distant from the ordinary site of colonization by shaping the host immune system [<xref rid="cit0039" ref-type="bibr">39</xref>]. (2) The virulence factors, such as pro-inflammatory urease [<xref rid="cit0040" ref-type="bibr">40</xref>], outer membrane vesicles [<xref rid="cit0041" ref-type="bibr">41</xref>,<xref rid="cit0042" ref-type="bibr">42</xref>] and the gut-brain axis disruption [<xref rid="cit0043" ref-type="bibr">43</xref>] as well as changes in the gut microbiota [<xref rid="cit0044" ref-type="bibr">44</xref>] may be involved in the pathogenesis of Alzheimer&#x02019;s disease. A growing number of research have provided evidence of the association between AD and periodontitis [<xref rid="cit0045" ref-type="bibr">45</xref>,<xref rid="cit0046" ref-type="bibr">46</xref>]. (3) Systemic inflammation mediation was one of the possible reasons for periodontal-related decline in cognitive abilities in AD patients [<xref rid="cit0047" ref-type="bibr">47</xref>]. The relation between incident all-cause and AD dementia in the context of periodontal pathogens was to be examine for the first time, which may provide new insights for subsequent related research.</p></sec><sec disp-level="2" id="s0002-s2003"><title>Oral lichen planus</title><p>OLP is an inflammatory disorder mediated by the immune system, characterized by distinct lesions affecting the skin and mucous membranes, particularly occurring on the buccal mucosa [<xref rid="cit0048" ref-type="bibr">48</xref>]. In 2010, the association between <italic toggle="yes">H. pylori</italic> infection and OLP was reported [<xref rid="cit0049" ref-type="bibr">49</xref>]. In a study, PCR was used to detect <italic toggle="yes">H. pylori</italic> in oral biopsy samples from 20 patients with erosive OLP and 20 with non-erosive OLP, while histopathological examination and PCR were conducted to detect <italic toggle="yes">H. pylori</italic> in gastric biopsy specimens. It found that 45% (18/40) of the patients (9 with erosive and 9 with non-erosive OLP) had positive histopathological results for gastric <italic toggle="yes">H. pylori</italic>. In patients who was negative for gastric <italic toggle="yes">H. pylori</italic> by histopathological examination, PCR results gave consistent results, which was corresponds to the reported sensitivity of 95% for histological detection of <italic toggle="yes">H. pylori</italic> in gastric mucosa. Histopathological examination failed to detect the presence of <italic toggle="yes">H. pylori</italic> in oral biopsies, but PCR testing gave positive results for all erosive OLP patients who were all gastric <italic toggle="yes">H. pylori</italic> positive. While no evidence of oral <italic toggle="yes">H. pylori</italic> was found in non-erosive OLP patients using either of these methods [<xref rid="cit0049" ref-type="bibr">49</xref>,<xref rid="cit0050" ref-type="bibr">50</xref>]. This study implied a possible pathogenic connection between <italic toggle="yes">H. pylori</italic> and erosive OLP Similar to this result, another study has also revealed a correlation between erosive OLP and <italic toggle="yes">H. pylori</italic> infection [<xref rid="cit0008" ref-type="bibr">8</xref>]. Researchers further investigated changes in the oral microbiota of these patients. They found that the OLP group exhibited significantly higher &#x003b1;-diversity of oral microbiota and notable differences in &#x003b2;-diversity. Furthermore, higher levels of inflammatory cytokines of IL-6, IL-8, and IL-17 were in the saliva of the OLP group [<xref rid="cit0008" ref-type="bibr">8</xref>]. Gastric inflammatory cytokines induced by <italic toggle="yes">H. pylori</italic> infection can reach the oral cavity via blood circulation, to modulate the local immune microenvironment and exacerbate inflammatory responses may be one of the potential mechanisms [<xref rid="cit0051" ref-type="bibr">51</xref>]. The reduction in the abundance of dominant bacteria in saliva of OLP patients can lead to dysbiosis of the microbial community and facilitate the colonization of other bacteria.</p></sec><sec disp-level="2" id="s0002-s2004"><title>Oral squamous cell carcinoma</title><p>OSCC is the most prevalent malignancy within the oral cavity. Despite technological advancements in treatment modalities, patient survival rates are low in the late-stage diagnoses [<xref rid="cit0052" ref-type="bibr">52</xref>]. The debate persists regarding the existence of <italic toggle="yes">H. pylori</italic> in OSCC and the role it plays. A study reported no conclusive evidence of <italic toggle="yes">H. pylori</italic> infection in specimens from OSCC patients by immunohistochemistry and quantitative polymerase chain reaction (qPCR) [<xref rid="cit0053" ref-type="bibr">53</xref>]. Another study proposed a possible negative link between <italic toggle="yes">H. pylori</italic> and OSCC [<xref rid="cit0054" ref-type="bibr">54</xref>]. These observations implied this bacterium may not significantly contribute to the pathogenesis of OSCC. However, a recently published article shed new light on this topic. In this study, 32.6% (15/46) of the OSCC samples demonstrated immunohistochemical positive for <italic toggle="yes">H. pylori</italic>, whereas all 21&#x000a0;healthy controls tested negative. Moreover, 7 of the 15 tested cases were confirmed to have a positive presence of <italic toggle="yes">H. pylori</italic> by culture. Notably, cases that tested positive for <italic toggle="yes">H. pylori</italic> were more commonly linked to advanced pathological tumor stages and reduced overall survival rates [<xref rid="cit0009" ref-type="bibr">9</xref>]. These seeming contradictions between OSCC and <italic toggle="yes">H. pylori</italic> infection underscore the necessity for a more in-depth exploration to elucidate the potential involvement of <italic toggle="yes">H. pylori</italic> in this malignancy.</p></sec><sec disp-level="2" id="s0002-s2005"><title>Aphthous stomatitis</title><p>Recurrent aphthous stomatitis (RAS), a common oral mucosal disorder, is distinguished by cyclical recurring painful ulcers [<xref rid="cit0055" ref-type="bibr">55</xref>]. It is suggested that association exists between RAS and <italic toggle="yes">H. pylori</italic> infection. Eradication of <italic toggle="yes">H. pylori</italic> could alleviate the manifestations of RAS, prolong the duration of remission, and decrease the incidence of RAS relapses [<xref rid="cit0056" ref-type="bibr">56</xref>]. Patients who were positive of serum and saliva <italic toggle="yes">H. pylori</italic> antibodies were reported to have more severe symptoms of RAS. After successful eradication therapy, significant improvement was shown in RAS recurrence and symptoms, with a longer interval between recurrence [<xref rid="cit0057" ref-type="bibr">57</xref>]. Beh&#x000e7;et&#x02019;s syndrome (BS), a systemic inflammatory disorder, involves multiple organ lesions such as skin, eyes, oropharyngeal mucosa, and gastrointestinal tract, with oral aphthous ulceration as the most prominent clinical manifestation [<xref rid="cit0058" ref-type="bibr">58</xref>]. BS patients exhibited a notably higher prevalence of <italic toggle="yes">cagA</italic> positivity among those <italic toggle="yes">H. pylori</italic>-seropositive individuals [<xref rid="cit0059" ref-type="bibr">59</xref>]. Successfully eradication therapy has been shown to result in improvements in clinical manifestations, including ulcers in the oral and genital and lesions [<xref rid="cit0058" ref-type="bibr">58</xref>,<xref rid="cit0060" ref-type="bibr">60</xref>].</p><p>A growing number of clinical and fundamental research has preliminarily uncovered a link between oral <italic toggle="yes">H. pylori</italic> infection and various oral diseases. However, different detection methods for <italic toggle="yes">H. pylori</italic> may lead to different results, like the association that we mentioned above between <italic toggle="yes">H. pylori</italic> and OLP. In the diagnosis of <italic toggle="yes">H. pylori</italic> infection, at least two biopsies histological examination remains the &#x02018;gold standard&#x02019; for determining <italic toggle="yes">H. pylori</italic> infection and immunostaining with anti-<italic toggle="yes">H. pylori</italic> antibodies could enhance the sensitivity [<xref rid="cit0061" ref-type="bibr">61</xref>,<xref rid="cit0062" ref-type="bibr">62</xref>]. However, the accuracy and sensitivity of this method for detecting <italic toggle="yes">H. pylori</italic> in oral biopsies still warrant investigation. Since the application of PCR to the detection of <italic toggle="yes">H. pylori</italic>, this method has been applied in detecting <italic toggle="yes">H. pylori</italic> from gastric biopsies, saliva, feces, and variable specimens, with over 95% of sensitivity and specificity [<xref rid="cit0061" ref-type="bibr">61</xref>]. The use of nested PCR technology can significantly enhance the detection rate of <italic toggle="yes">H. pylori</italic> [<xref rid="cit0063" ref-type="bibr">63</xref>]. The urea breath test (UBT) remains the most popular and accurate non-invasive method for diagnosing <italic toggle="yes">H. pylori</italic> infection, with a sensitivity and specificity approaching 95% under standardized procedures. However, this method can yield false-negative results due to the use of medications such as proton pump inhibitors (PPIs) and antibiotics, and gastrointestinal bleeding. Meanwhile, false-positive results can occur due to the presence of other urease-producing pathogens in the stomach [<xref rid="cit0061" ref-type="bibr">61</xref>]. Therefore, the appropriate selection of detection methods with higher specificity and sensitivity is crucial for clarifying the relationship between oral diseases and <italic toggle="yes">H. pylori</italic>. The association between <italic toggle="yes">H. pylori</italic> and oral diseases is summarized in <xref rid="f0001" ref-type="fig">Figure 1</xref>.<fig position="float" id="f0001" fig-type="figure"><label>Figure 1.</label><caption><p>Oral <italic toggle="yes">H. pylori</italic> infection has been associated with an elevated risk of periodontitis, dental caries, and other oral pathologies, such as OLP and RAS, potentially exacerbating their severity and influencing treatment outcomes. The association with OSCC remains contentious, although it may be associated with a less favorable prognosis. The eradication of <italic toggle="yes">H. pylori</italic> could potentially ameliorate symptoms in RAS. OLP, oral lichen planus; RAS, recurrent aphthous stomatitis; OSCC, oral squamous cell carcinoma.</p></caption><alternatives><graphic xlink:href="ZJOM_A_2469896_F0001_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="ZJOM_A_2469896_F0001_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec></sec><sec disp-level="1" id="s0003"><title>H. pylori and oral microbiome</title><p>The oral microbiome, the second most complicated community surpassed only by the colon microflora among human microbial ecosystems, comprises over 700 species of microorganisms, the majority of which are indigenous [<xref rid="cit0064" ref-type="bibr">64</xref>]. The oral cavity comprises various structures, including mucosal surfaces, hard tissues, and exocrine gland tissues and each of these structures supports a unique microbiota composition [<xref rid="cit0065" ref-type="bibr">65</xref>]. The primary bacterial phyla within the oral cavity of healthy adults include <italic toggle="yes">Firmicutes</italic>, <italic toggle="yes">Bacteroidetes</italic>, <italic toggle="yes">Proteobacteria</italic>, <italic toggle="yes">Actinobacteria</italic>, and <italic toggle="yes">Fusobacteria</italic> [<xref rid="cit0066" ref-type="bibr">66</xref>], with <italic toggle="yes">Streptococcus</italic> being the primary genus [<xref rid="cit0065" ref-type="bibr">65</xref>,<xref rid="cit0067" ref-type="bibr">67</xref>]. Compared to other body sites, the oral microbiota exhibited the highest &#x003b1; diversity but the lowest &#x003b2; diversity, and there was minimal variation in oral microbiota composition among individuals [<xref rid="cit0065" ref-type="bibr">65</xref>].</p><p><italic toggle="yes">H. pylori</italic> may reshape the composition pattern of the oral microbiota by altering the diversity of the oral microbial community. High-throughput sequencing of saliva samples has demonstrated distinct oral community structures between <italic toggle="yes">H. pylori</italic> positive and negative groups. The &#x003b1;-diversity of <italic toggle="yes">H. pylori</italic>-infected subjects is similar to that of non-infected subjects; however, differences were showed in &#x003b2;-diversity among <italic toggle="yes">H. pylori</italic>-infected and non-infected subjects, as well as before and after <italic toggle="yes">H. pylori</italic> eradication, indicating the difference of salivary microbial community structures among these groups [<xref rid="cit0067" ref-type="bibr">67</xref>]. Compare to <italic toggle="yes">H. pylori</italic>-negative individuals, <italic toggle="yes">H. pylori</italic>-positive individuals, confirmed by <sup>13</sup>C- UBT, had a higher diversity of the oral microbiota, since the indicators of &#x003b1; and &#x003b2; diversity showed increasing richness and evenness [<xref rid="cit0068" ref-type="bibr">68</xref>].</p><p>Unlike the <italic toggle="yes">vacA</italic> gene expressed in virtually all <italic toggle="yes">H. pylori</italic> isolates, the cytotoxin-associated gene pathogenicity island (cag PAI) is expressed only in a subset of strains, which typically signifies a higher virulence [<xref rid="cit0069" ref-type="bibr">69</xref>]. A study has found that the gene expression of the <italic toggle="yes">H. pylori</italic> virulence factor <italic toggle="yes">cagA</italic> is associated with the composition of the oral microbiota and bacterial interactions [<xref rid="cit0070" ref-type="bibr">70</xref>]. In this research, from <italic toggle="yes">H. pylori</italic>&#x02212; through <italic toggle="yes">H. pylori</italic>+/<italic toggle="yes">cagA</italic>&#x02212; to <italic toggle="yes">H. pylori</italic>+/<italic toggle="yes">cagA</italic>+ subjects, a decreasing trend of &#x003b1; diversity was observed within the tongue coating flora. <italic toggle="yes">Actinobacteria</italic> was less abundant, while genera <italic toggle="yes">Akkermansia</italic>, <italic toggle="yes">Meganomas</italic>, and <italic toggle="yes">Ruminococcus</italic> were enriched in <italic toggle="yes">H. pylori</italic>+/<italic toggle="yes">cagA</italic>&#x02212; group. This study further indicated that in <italic toggle="yes">H. pylori</italic>+/<italic toggle="yes">cagA</italic>+ patients, the reduced total amount of bacterial interactions, where co&#x02010;occurrence relationships dominate, implied a less stable bacterial community structure and a weaker resistance to potentially pathogenic microorganisms. The observed elevated LPS biosynthesis production by <italic toggle="yes">H. pylori</italic> cagA+ strains reached the oral cavity through the bloodstream, also potentially contributing to this process [<xref rid="cit0070" ref-type="bibr">70</xref>].</p><p>It is suggested that the influence of <italic toggle="yes">H. pylori</italic> on the oral microbiota may exhibit a circadian rhythm. Patients with <italic toggle="yes">H. pylori</italic> infection (UBT positive) exhibit lower &#x003b1;-diversity in the buccal mucosa microbiota. At the phylum level, there was a significant enrichment of <italic toggle="yes">Proteobacteria</italic>, while a significant reduction in <italic toggle="yes">Firmicutes</italic> and <italic toggle="yes">Fusobacteria</italic> [<xref rid="cit0051" ref-type="bibr">51</xref>]. The authors attribute these changes to the metabolic activities of <italic toggle="yes">H. pylori</italic> during the daytime. However, human daytime activities are more diverse, and other physiological activities like dietary intake may also impact the oral microbiota. While <italic toggle="yes">H. pylori</italic> infection may cause such changes, scarce studies have been found. Thus, further in-depth research is needed to uncover the intrinsic connection between this phenomenon and <italic toggle="yes">H. pylori</italic> infection.</p><p>Due to the close relationship between the oral cavity and the digestive tract, some gastrointestinal diseases can affect the oral microbiota, but this impact is influenced by the infection status of <italic toggle="yes">H. pylori</italic>. In chronic atrophic gastritis (CAG) patients, the abundance of several oral bacteria including the genus <italic toggle="yes">Neisseria</italic>, <italic toggle="yes">Staphylococcus</italic>, and <italic toggle="yes">Haemophilus</italic> was lower in type I <italic toggle="yes">H. pylori</italic> infection subjects (serum anti-CagA and/or anti-VacA positive) than in type II <italic toggle="yes">H. pylori</italic> infection subjects (serum anti-CagA and anti-VacA negative) [<xref rid="cit0071" ref-type="bibr">71</xref>]. This suggested virulent <italic toggle="yes">H. pylori</italic> infection can reduce the abundance of the dominant oral bacterial community in the stomach of CAG patients, but the mechanism is unclear. One research reported <italic toggle="yes">H. pylori</italic> infection attenuated the increase of the &#x003b2;-diversity in oral microflora in reflux esophagitis. It may be attributed to the changes in microbial community structure induced by <italic toggle="yes">H. pylori</italic> infection, which in turn affects the normal microbial metabolism and interactions [<xref rid="cit0072" ref-type="bibr">72</xref>].</p></sec><sec disp-level="1" id="s0004"><title>H. pylori and oral microbiome</title><sec disp-level="2" id="s0004-s2001"><title>H. pylori and Streptococci</title><p><italic toggle="yes">S. mutans</italic> is the primary cariogenic bacterium, predominantly acquired in early childhood through mother-to-child transmission. By synthesizing extracellular polysaccharides and promoting bacterial adhesion and aggregation, this bacterium colonizes the tooth surface to form dental plaque. Here, it thrives and metabolizes to produce acids, leading to dental tissue demineralization and cavity formation [<xref rid="cit0073" ref-type="bibr">73</xref>,<xref rid="cit0074" ref-type="bibr">74</xref>]. Research has indicated that <italic toggle="yes">S. mutans</italic> is involved in the colonization process of <italic toggle="yes">H. pylori</italic>. A study on the role of <italic toggle="yes">S. mutans</italic> in the colonization of <italic toggle="yes">H. pylori</italic>, by applying PCR and nested PCR to detect the presence of MKD and <italic toggle="yes">ureA</italic> gene of <italic toggle="yes">S. mutans</italic> and <italic toggle="yes">H. pylori</italic>, respectively, showed that <italic toggle="yes">H. pylori</italic> was absent in rats infected by <italic toggle="yes">H. pylori</italic> alone, while was present in all rats that were co-infected by <italic toggle="yes">S. mutans</italic> and <italic toggle="yes">H. pylori</italic>. The finding preliminary identified the role of <italic toggle="yes">S. mutans</italic> in the colonization of <italic toggle="yes">H. pylori</italic> [<xref rid="cit0075" ref-type="bibr">75</xref>]. Subsequent in vitro experiments revealed the pattern of colonization. The location of <italic toggle="yes">H. pylori</italic> within a biofilm is contingent upon the coexistence of <italic toggle="yes">S. mutans</italic>. Specifically, in the absence of <italic toggle="yes">S. mutans</italic>, <italic toggle="yes">H. pylori</italic> adhered in a monolayer on flat surfaces. Conversely, when <italic toggle="yes">S. mutans</italic> was present, <italic toggle="yes">H. pylori</italic> was dispersed throughout the biofilm, leading to a notable augmentation in the quantity of <italic toggle="yes">H. pylori</italic> in the co-culture system [<xref rid="cit0075" ref-type="bibr">75</xref>]. <italic toggle="yes">H. pylori</italic> may also promote colonization of <italic toggle="yes">S. mutans</italic> by affecting competition relationship between <italic toggle="yes">Streptococci</italic>. A study on the impact of <italic toggle="yes">H. pylori</italic> culture supernatant on dual-species oral biofilms found that the supernatant of <italic toggle="yes">H. pylori</italic> inhibited the biofilm formation and EPS production of both <italic toggle="yes">S. mutans</italic> and <italic toggle="yes">Streptococcus sanguinis</italic>, but with stronger inhibitory effect on <italic toggle="yes">S. sanguinis</italic> [<xref rid="cit0076" ref-type="bibr">76</xref>]. Due to the competition between the two <italic toggle="yes">Streptococci</italic>, increasing levels of <italic toggle="yes">S. sanguinis</italic> result in the delay of <italic toggle="yes">S. mutans</italic> in the colonization. <italic toggle="yes">H. pylori</italic> supernatant induced a significant increase in the expression of <italic toggle="yes">S. mutans</italic> and acid-producing genes, such as <italic toggle="yes">ldh</italic>, <italic toggle="yes">nlmA</italic>, and <italic toggle="yes">nlmC</italic> [<xref rid="cit0076" ref-type="bibr">76</xref>]. Therefore, the presence of <italic toggle="yes">H. pylori</italic> may affect the balance between <italic toggle="yes">S. mutans</italic> and <italic toggle="yes">S</italic>. sanguinis within biofilms, promoting the colonization of <italic toggle="yes">S. mutans</italic> and altering the expression of genes related to its pathogenicity.</p><p>There may be complex interactions between <italic toggle="yes">H. pylori</italic> and <italic toggle="yes">Streptococcus</italic> that can affect growth patterns, metabolic activity and drug resistance. <italic toggle="yes">Streptococcus mitis</italic>, an integral part of the human oral microbiota, was traditionally regarded as a commensal bacterium, yet evidence suggests it may also act as an opportunistic pathogen, associated with certain oral and systemic diseases [<xref rid="cit0077" ref-type="bibr">77</xref>]. During in vitro co-culture, <italic toggle="yes">S. mitis</italic> inhibited the growth of <italic toggle="yes">H. pylori</italic> specifically. In the same study, researchers also found that <italic toggle="yes">H. pylori</italic> can release diffusible factors that promote the survival of <italic toggle="yes">S. mitis</italic> during the stationary phase in vitro [<xref rid="cit0078" ref-type="bibr">78</xref>]. This may be a result of the expression of <italic toggle="yes">S. mitis</italic> phosphoglycerate kinase, one of the surface-associated proteins expressed by <italic toggle="yes">Streptococci</italic> [<xref rid="cit0079" ref-type="bibr">79</xref>]. During co-culture with <italic toggle="yes">S. mitis</italic>, <italic toggle="yes">H. pylori</italic> exhibited lower ATP levels compared to its viable form, but higher than dead cells, and also displayed a coccoid morphology. This suggests that <italic toggle="yes">H. pylori</italic> entered a viable but non-culturable state during co-culture, which is induced by the presence of <italic toggle="yes">S. mitis</italic> [<xref rid="cit0078" ref-type="bibr">78</xref>]. In addition to promoting coccoid transformation of <italic toggle="yes">H. pylori</italic>, mutual inhibition between <italic toggle="yes">streptococci</italic> and <italic toggle="yes">H. pylori</italic> has been reported in different studies. In one study, The supernatant of <italic toggle="yes">S. mutans</italic> and <italic toggle="yes">P. intermedia</italic> inhibited the growth of <italic toggle="yes">H. pylori</italic> and induced coccoid form transformation [<xref rid="cit0080" ref-type="bibr">80</xref>]. In another study, the growth of <italic toggle="yes">H. pylori</italic> was significantly inhibited by <italic toggle="yes">S. mutans</italic> JP2 and Ingbritt, three <italic toggle="yes">Prevotella</italic> species, and <italic toggle="yes">Streptococcus sobrinus</italic> 6715 remarkably. These inhibitory effects could be effectively negated through either heat treatment or protease digestion. The findings suggested that specific proteins secreted by these oral bacterial species may possess bactericidal properties, consequently inhibiting <italic toggle="yes">H. pylori</italic> strains proliferation [<xref rid="cit0081" ref-type="bibr">81</xref>].</p></sec><sec disp-level="2" id="s0004-s2002"><title>H. pylori and P. gingivalis</title><p>Among approximately 700 species in the oral cavity, <italic toggle="yes">P. gingivalis</italic>, a Gram-negative anaerobic bacterium, is pivotal in the development of periodontitis [<xref rid="cit0082" ref-type="bibr">82</xref>]. <italic toggle="yes">P. gingivalis</italic> adhere to mucosal surfaces, periodontal pocket epithelium, and other bacterial surfaces through a series of adhesion factors, such as bacterial hairs, hemagglutinins, and proteases. Furthermore, <italic toggle="yes">P. gingivalis</italic> secretes proteases, endotoxins, and organic acids and other virulence factors, which degrade host proteins and contribute to immune evasion, ultimately leading to the destruction of periodontal tissues [<xref rid="cit0083" ref-type="bibr">83</xref>]. In an in vitro co-culture study of <italic toggle="yes">P. gingivalis</italic> and <italic toggle="yes">H. pylori</italic>, the genes expression of <italic toggle="yes">hagA, hagC</italic> and <italic toggle="yes">rgpB</italic> was increased in <italic toggle="yes">P. gingivalis</italic> after co-incubation [<xref rid="cit0084" ref-type="bibr">84</xref>]. The hemagglutinins HagA and HagC was possibly relate to the increase of bacterial invasion, biofilm formation and hemagglutination, while arginine gingipain RgpB was related to the proteolytic activity of the enzyme [<xref rid="cit0084" ref-type="bibr">84</xref>].</p><p>The interaction between <italic toggle="yes">H. pylori</italic> and <italic toggle="yes">P. gingivalis</italic> may also mediated through inflammatory mechanisms. <italic toggle="yes">P. gingivalis</italic> can promote the expression and secretion of various ILs, and the involvement of <italic toggle="yes">H. pylori</italic> may influence this process. In a study, oral keratinocytes (OK) cells were infected with <italic toggle="yes">P. gingivalis</italic> that had been co-incubated with <italic toggle="yes">H. pylori</italic>. The mRNA expression levels of IL-8 and TNF-&#x003b1; in the OK cells were 3.1-fold and 3.4-fold higher, respectively, compared to uninfected cells. These elevated levels were significantly higher than those observed in OK cells that infected by <italic toggle="yes">P. gingivalis</italic> without co-incubation (1.8-fold and 1.7-fold, respectively) [<xref rid="cit0084" ref-type="bibr">84</xref>]. A significant increase of IL-8 protein levels was detected in media supplemented with the gingipain inhibitor TLCK [<xref rid="cit0084" ref-type="bibr">84</xref>]. The expression of indoleamine 2,3-dioxygenase (IDO) often higher in individuals with <italic toggle="yes">H. pylori</italic> infection, which paradoxically leads to a decrease in IL-17 expression [<xref rid="cit0085" ref-type="bibr">85</xref>]. IL-17 is the cytokine produced by T helper 17 (Th17) [<xref rid="cit0086" ref-type="bibr">86</xref>]. <italic toggle="yes">P. gingivalis</italic> can alter adaptive immune responses by promoting the differentiation and recruitment of CD4+ Th17 cells [<xref rid="cit0087" ref-type="bibr">87</xref>]. However, the downregulation of Th1 and Th17 responses induced by IDO, along with the upregulation of Th2 responses, may be the mechanism by which <italic toggle="yes">H. pylori</italic> evades the mucosal immunity, potentially facilitating its survival in subgingival plaque and gingival crevicular fluid.</p><p><italic toggle="yes">P. gingivalis</italic> typically expresses FimA and Mfa1, two different types of fimbriae that play a significant role in biofilm formation [<xref rid="cit0088" ref-type="bibr">88</xref>]. Depending on its nucleotide sequence, <italic toggle="yes">fimA</italic> can be categorized into multiple genotypes [<xref rid="cit0089" ref-type="bibr">89</xref>]. Studies have revealed the distribution of <italic toggle="yes">fimA</italic> correlates with the infection of <italic toggle="yes">H. pylori</italic>. The distribution of <italic toggle="yes">fimA</italic> genotypes, with <italic toggle="yes">fimA</italic> I and <italic toggle="yes">fimA</italic> II commonly detected in <italic toggle="yes">H. pylori</italic>-positive samples and <italic toggle="yes">fimA</italic> IV more prevalent in <italic toggle="yes">H. pylori</italic>-negative samples [<xref rid="cit0090" ref-type="bibr">90</xref>]. A meta-analysis revealed <italic toggle="yes">fimA</italic> II and <italic toggle="yes">fimA</italic> IV were most commonly observed in individuals with periodontal disease, linking them to the elevated risk of periodontitis [<xref rid="cit0091" ref-type="bibr">91</xref>]. <italic toggle="yes">H. pylori</italic> was frequently detected in dental plaque around the extracted tooth and in deep periodontal pockets in the presence of <italic toggle="yes">P. gingivalis</italic> with specific <italic toggle="yes">fimA</italic> genotype. Although <italic toggle="yes">H. pylori</italic> may not be the primary pathogenic factor in periodontitis, specific <italic toggle="yes">fimA</italic> genotypes of <italic toggle="yes">P. gingivalis</italic> could play a role in facilitating the colonization of <italic toggle="yes">H. pylori</italic> [<xref rid="cit0090" ref-type="bibr">90</xref>]. However, the specific mechanisms remain unclear. <italic toggle="yes">P. gingivalis</italic> produces butyric acid, which has been consider to contribute to the progression of periodontal disease [<xref rid="cit0092" ref-type="bibr">92</xref>]. This metabolite of <italic toggle="yes">P. gingivalis</italic> also affects the colonization of <italic toggle="yes">H. pylori</italic>. Study showed that the supernatant of the <italic toggle="yes">P. gingivalis</italic> can disrupt the cellular membrane of <italic toggle="yes">H. pylori</italic>, which was similar to the effects observed with butyrate-treated <italic toggle="yes">H. pylori</italic> [<xref rid="cit0093" ref-type="bibr">93</xref>]. Elevated levels of butyrate have been found in gingival crevicular fluids in patients with periodontitis [<xref rid="cit0094" ref-type="bibr">94</xref>]. Therefore, the colonization of <italic toggle="yes">H. pylori</italic> may be influenced in the oral cavity.</p><p>Previous study reported the ability of co-aggregation of <italic toggle="yes">H. pylori</italic> with certain subgingival bacterial species. For example, <italic toggle="yes">H. pylori</italic> can adhere to <italic toggle="yes">Fusobacterium</italic> spp. specifically [<xref rid="cit0095" ref-type="bibr">95</xref>]. Clinical isolated strains of <italic toggle="yes">H. pylori</italic> were capable of co-aggregating with <italic toggle="yes">P. gingivalis</italic> ATCC 33,277 and FDC381, <italic toggle="yes">Fusobacterium nucleatum</italic> ATCC 25,586 and #2. This mutual interaction between <italic toggle="yes">P. gingivalis</italic> or <italic toggle="yes">F. nucleatum</italic> and <italic toggle="yes">H. pylori</italic> could be disrupted by heating, certain amino acids (arginine, lysine), and EDTA. The proteolytic activity of arginine and fimbriae may serve as crucial factors in preventing this coaggregation process [<xref rid="cit0081" ref-type="bibr">81</xref>]. Another periodontopathic microorganism, <italic toggle="yes">Campylobacter rectus</italic>, possesses proteins that act as antigens similar to those found in <italic toggle="yes">H. pylori</italic> strains. This similarity may be linked to triggering immune system reactions that lead to damage in periodontal tissues and the stomach [<xref rid="cit0096" ref-type="bibr">96</xref>].</p></sec><sec disp-level="2" id="s0004-s2003"><title>H. pylori and C. albicans</title><p><italic toggle="yes">C. albicans</italic> is generally a benign component of the native microbiota, frequently residing in the gastrointestinal and reproductive tract and oral cavity of most healthy humans. However, it becomes opportunistic pathogenic when the immune system is compromised, which leads to severe and potentially fatal infections [<xref rid="cit0097" ref-type="bibr">97</xref>]. Oral fungi are often considered pathogens, predominantly associated with disease. Nevertheless, the interplay between bacteria and fungi is crucial for maintaining oral health and should be recognized as a significant symbiotic relationship [<xref rid="cit0098" ref-type="bibr">98</xref>]. Interaction occurs between <italic toggle="yes">C. albicans</italic> and <italic toggle="yes">H. pylori</italic>, facilitating growth, dissemination, and infection of <italic toggle="yes">C. albicans</italic> under adverse conditions [<xref rid="cit0099" ref-type="bibr">99</xref>].</p><p>The vacuoles of <italic toggle="yes">C. albicans</italic> can provide a unique niche for <italic toggle="yes">H. pylori</italic>, safeguarding it from environmental stress and supplying essential nutrients for its growth and reproduction, including ergosterol [<xref rid="cit0100" ref-type="bibr">100</xref>]. <italic toggle="yes">H. pylori</italic> DNA can be detected within yeast cells extracted from the oral cavity [<xref rid="cit0101" ref-type="bibr">101</xref>]. <italic toggle="yes">C. albicans</italic> is the predominant fungal species in the oral cavity, as evidenced by a study showing a high detection rate of oral yeast at 33.3% in 72 oral swab samples, with <italic toggle="yes">C. albicans</italic> constituting 79.2% of the detected yeast species. In yeasts exhibiting bacterium-like organelles, <italic toggle="yes">H. pylori</italic> DNA was successfully amplified [<xref rid="cit0102" ref-type="bibr">102</xref>]. <italic toggle="yes">H. pylori</italic> residing within <italic toggle="yes">C. albicans</italic> can be released through secreted vesicles or as free bacterium, and the vesicles carrying <italic toggle="yes">H. pylori</italic> may protect the bacteria from harm and potentially facilitate its entry into new target cells [<xref rid="cit0103" ref-type="bibr">103</xref>]. Collectively, these studies provided evidence supporting the possibility of a symbiotic relationship between <italic toggle="yes">H. pylori</italic> and oral <italic toggle="yes">Candida</italic>, which may benefit the spread and reinfection of <italic toggle="yes">H. pylori</italic> in the gastrointestinal tract.</p><p>Adverse conditions, such as antibiotics, acidic environments, unsuitable temperatures, and anaerobic conditions, can induce <italic toggle="yes">H. pylori</italic> to enter the vacuoles of <italic toggle="yes">C. albicans</italic>. <italic toggle="yes">C. albicans</italic> exhibits high resilience to adversity and can proliferate in acidic environments [<xref rid="cit0104" ref-type="bibr">104</xref>]. A low pH at 2&#x02013;3 [<xref rid="cit0104" ref-type="bibr">104</xref>], and in some cases at 3 or 4 [<xref rid="cit0105" ref-type="bibr">105</xref>], corresponds to the optimal conditions for the <italic toggle="yes">H. pylori</italic>&#x02019; s entry into <italic toggle="yes">C. albicans</italic>. <italic toggle="yes">H. pylori</italic>, the amoxicillin-sensitive strains, sheltered within vacuoles, can be protected from the antibacterial effects [<xref rid="cit0104" ref-type="bibr">104</xref>]. The optimal temperature for growth of <italic toggle="yes">H. pylori</italic> is 35&#x02013;37&#x000b0;C [<xref rid="cit0106" ref-type="bibr">106</xref>], and bacteria-like bodies (BLBs) within yeast cells containing bacterial bodies could be detected after 48&#x02009;hours of incubation at temperatures ranging from 4&#x000b0;C to 40&#x000b0;C. BLBs were detected faster at 4&#x000b0;C, 25&#x000b0;C, and 40&#x000b0;C compared to 37&#x000b0;C, with the highest mean count observed at 40&#x000b0;C [<xref rid="cit0107" ref-type="bibr">107</xref>]. <italic toggle="yes">H. pylori</italic> is microaerophilic, and can grow in environments rich in carbon dioxide (5% to 10%) [<xref rid="cit0106" ref-type="bibr">106</xref>], but anaerobic conditions promote the formation of BLBs [<xref rid="cit0108" ref-type="bibr">108</xref>]. Additionally, nutritional deficiency can be an entering-stimulus for <italic toggle="yes">H. pylori</italic>. However, the accommodating effect may be diminished when the <italic toggle="yes">Candida</italic> is also in a state of nutrient deficiency [<xref rid="cit0109" ref-type="bibr">109</xref>]. Strong association was established between <italic toggle="yes">C. albicans</italic> and early childhood caries [<xref rid="cit0110" ref-type="bibr">110</xref>,<xref rid="cit0111" ref-type="bibr">111</xref>], and co-infection of <italic toggle="yes">C. albicans</italic> with <italic toggle="yes">S. mutans</italic> is closely related to the recurrence of dental caries [<xref rid="cit0112" ref-type="bibr">112</xref>]. Further research is necessary to investigate whether <italic toggle="yes">C. albicans</italic> serves as a unique habitat for <italic toggle="yes">H. pylori</italic> within carious lesions, enabling its survival in caries-inducing environments, and to assess whether this particular form of <italic toggle="yes">H. pylori</italic> could potentially serve as a source for infection and reinfection. The interaction between <italic toggle="yes">H. pylori</italic> and oral microbiome is shown in <xref rid="f0002" ref-type="fig">Figure 2</xref>.<fig position="float" id="f0002" fig-type="figure"><label>Figure 2.</label><caption><p><italic toggle="yes">H. pylori</italic> interacts with oral microorganisms, which may influence the pathogenicity and ecological balance within the oral cavity. The bidirectional interaction between <italic toggle="yes">H. pylori</italic> and <italic toggle="yes">Streptococci</italic> influences the spatial distribution of <italic toggle="yes">H. pylori</italic>, with <italic toggle="yes">Streptococci</italic> modulating its growth and inducing a coccoid morphological transition. In turn, <italic toggle="yes">H. pylori</italic> perturbs the homeostasis of the dental plaque microbiota. <italic toggle="yes">H. pylori</italic> can modulate the virulence of <italic toggle="yes">P. gingivalis</italic>, with virulence factor genes of <italic toggle="yes">P. gingivalis</italic> detected in <italic toggle="yes">H. pylori</italic>-positive oral samples. <italic toggle="yes">P. gingivalis</italic> can co-aggregate with <italic toggle="yes">H. pylori</italic>. <italic toggle="yes">C. albicans</italic> may form a symbiotic relationship with <italic toggle="yes">H. pylori</italic>. Adverse conditions may facilitate the entry of <italic toggle="yes">H. pylori</italic> into <italic toggle="yes">C. albicans.</italic>.</p></caption><alternatives><graphic xlink:href="ZJOM_A_2469896_F0002_OC" content-type="color" specific-use="web-only" position="float"/><graphic xlink:href="ZJOM_A_2469896_F0002_PB" content-type="black-white" specific-use="print-only" position="float"/></alternatives></fig></p></sec></sec><sec disp-level="1" id="s0005"><title>The impact of H. pylori eradication therapy on oral microbiota</title><p>Discrepancies were found in the compositional structure of salivary microbiota at the phylum and genus levels between individuals who were positive or negative for oral <italic toggle="yes">H. pylori</italic>. Individuals with a positive <italic toggle="yes">H. pylori</italic> status exhibited an elevation in the abundance of <italic toggle="yes">Firmicutes</italic> and a concurrent decline in <italic toggle="yes">Proteobacteria</italic> and <italic toggle="yes">Verrucomicrobia</italic>. The <italic toggle="yes">H. pylori</italic>-negative cohort exhibited higher values for most network topological indices, implying a reduction in bacterial interactions during <italic toggle="yes">H. pylori</italic> infection [<xref rid="cit0113" ref-type="bibr">113</xref>]. On one hand, alterations in the composition of the oral microbiota occur when <italic toggle="yes">H. pylori</italic> infection is present. A study identified 16 significantly different genera between infected and non-infected groups, with genera such as <italic toggle="yes">Acinetobacter</italic>, <italic toggle="yes">Ralstonia</italic>, <italic toggle="yes">Leptothrix</italic> showing higher abundance in infected patients, while <italic toggle="yes">Alloprevotella</italic>, <italic toggle="yes">Aggregatibacter</italic>, <italic toggle="yes">Klebsiella</italic> were more prevalent in uninfected subjects [<xref rid="cit0067" ref-type="bibr">67</xref>]. <italic toggle="yes">H. pylori</italic> may affect the metabolism of normal oral flora or its activity and metabolites may affect oral microbial balance. On the other hand, the composition of the oral microbiota also varies before and after <italic toggle="yes">H. pylori</italic> infection and the eradication of the bacterium, with specific differences noted among various studies. One study reported that certain oral bacteria, including <italic toggle="yes">Prevotellaceae, Streptococcaceae, Caulobacteraceae</italic>, and <italic toggle="yes">Lactobacillaceae</italic>, were significantly enriched following <italic toggle="yes">H. pylori</italic> eradication. In contrast, <italic toggle="yes">Veillonellaceae, Weeksellaceae, Peptostreptococcaceae, Spirochaetaceae and Neisseriaceae</italic> were enriched in the groups where eradication failed [<xref rid="cit0114" ref-type="bibr">114</xref>]. However, another study showed that after conducting successful eradication therapy, the genera <italic toggle="yes">Ralstonia</italic>, <italic toggle="yes">Ptotrichia</italic>, <italic toggle="yes">Ingomonas</italic> increased, while <italic toggle="yes">Ochrobactrum</italic> decreased after successful eradication [<xref rid="cit0067" ref-type="bibr">67</xref>].</p><p>A balanced oral microbiota is pivotal in eliminating <italic toggle="yes">H. pylori</italic> and the maintenance of metabolic homeostasis in humans. <italic toggle="yes">H. pylori</italic> eradication causes disruptions to the host&#x02019;s microbial communities, which may be the effect of the different medications in the treatment regimen [<xref rid="cit0067" ref-type="bibr">67</xref>,<xref rid="cit0115" ref-type="bibr">115</xref>]. Eradication therapy for <italic toggle="yes">H. pylori</italic> can alter the composition and diversity of oral microflora, potentially contributing to the therapeutic effects of antibiotic therapy [<xref rid="cit0114" ref-type="bibr">114</xref>]. The management of <italic toggle="yes">H. pylori</italic> infections is currently reliant on a combined use of antibiotics including amoxicillin, clarithromycin, and bismuth compounds, and with PPIs as the commonly used antisecretory medication [<xref rid="cit0116" ref-type="bibr">116</xref>]. Numerous studies have suggested that medications related to the eradication of <italic toggle="yes">H. pylori</italic>, such as PPIs, bismuth drugs, potassium-competitive acid blockers (P-CABs), and antibiotics, have an influence on the oral flora, as shown in <xref rid="t0001" ref-type="table">Table 1</xref>.<table-wrap position="float" id="t0001"><label>Table 1.</label><caption><p>The impact and possible mechanisms of <italic toggle="yes">H. pylori</italic> eradication therapy on oral microbiota.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/></colgroup><thead><tr><th align="left">Medication</th><th align="center">Specimen/Bacterium</th><th align="center">Impacts</th><th align="center">Mechanisms</th><th align="center">Reference</th></tr></thead><tbody><tr><td rowspan="3" align="left">PPI<break/>(Esomeprazole)</td><td align="left">Saliva</td><td align="left"><italic toggle="yes">Streptococcus</italic> increased</td><td align="center">&#x02013;</td><td align="left">[<xref rid="cit0066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left">Gingival crevicular fluid</td><td align="left"><italic toggle="yes">Neisseria</italic> and <italic toggle="yes">Veillonella</italic> decreased; <italic toggle="yes">Fusobacterium</italic>, <italic toggle="yes">Leptotrichia</italic> and <italic toggle="yes">Streptococcus</italic> increased</td><td align="center">&#x02013;</td><td align="left">[<xref rid="cit0066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left">Faeces</td><td align="left"><italic toggle="yes">Streptococcus</italic> increased</td><td align="left">Facilitating the translocation of oral-originated <italic toggle="yes">Streptococci</italic> into the gut</td><td align="left">[<xref rid="cit0117" ref-type="bibr">117</xref>]</td></tr><tr><td rowspan="2" align="left">Bismuth</td><td align="left">Saliva</td><td align="left">Most <italic toggle="yes">H. pylori</italic>-enriched genera, including <italic toggle="yes">Ralstonia, Leptotrichia, Sphingomonas, Leptothrix, Oribacterium</italic>, and <italic toggle="yes">Acinetobacter</italic> increased after bismuth-containing quadruple therapy</td><td align="center">&#x02013;</td><td align="left">[<xref rid="cit0067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left"><italic toggle="yes">P. gingivalis</italic></td><td align="left">Restored the downregulation of IL-1B and TNF gene mRNA expression caused by <italic toggle="yes">P. gingivalis</italic> in HGECs and helped maintain the viability of HGECs</td><td align="left">Disrupted the iron acquisition, interfered energy metabolism and virulence of <italic toggle="yes">P. gingivalis</italic></td><td align="left">[<xref rid="cit0121" ref-type="bibr">121</xref>]</td></tr><tr><td rowspan="2" align="left">P-CAB(Vonoprazan)</td><td align="left">Saliva</td><td align="left">L-VA-dual: <italic toggle="yes">Bacteroidetes</italic> decreased, <italic toggle="yes">Proteobacteria</italic> increased;<break/>H-VA-dual: <italic toggle="yes">Firmicutes</italic> decreased, <italic toggle="yes">Proteobacteria</italic> increased</td><td align="center">&#x02013;</td><td align="left">[<xref rid="cit0068" ref-type="bibr">68</xref>]</td></tr><tr><td align="left">Tongue coating</td><td align="left">Eradication therapy suppressed the proliferation of <italic toggle="yes">Firmicutes</italic> and <italic toggle="yes">Lactobacillus</italic>;<break/>The supplementation of probiotics had no effect on the maintaining of oral microbiota.</td><td align="center">&#x02013;</td><td align="left">[<xref rid="cit0126" ref-type="bibr">126</xref>]</td></tr><tr><td align="left">Antibiotics</td><td align="left">Subgingival plaque</td><td align="left">A positive correlation between the use of tetracycline and the amount of <italic toggle="yes">Firmicutes.</italic></td><td align="center">&#x02013;</td><td align="left">[<xref rid="cit0127" ref-type="bibr">127</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p>Abbreviations: <italic toggle="yes">P. gingivalis</italic>, <italic toggle="yes">Porphyromonas gingivalis</italic>; HGECs, human gingival epithelial cells; L-VA-dual: low-dose vonoprazan and amoxicillin dual therapy; H-VA-dual: high-dose vonoprazan and amoxicillin dual therapy.</p></fn></table-wrap-foot></table-wrap></p><p>In healthy individuals, the salivary and periodontal pocket microbiota are predominantly composed of <italic toggle="yes">Firmicutes</italic>, <italic toggle="yes">Proteobacteria, Bacteroidetes</italic>, and <italic toggle="yes">Fusobacteria</italic> [<xref rid="cit0066" ref-type="bibr">66</xref>]. Research showed that the use of PPI has an effect on the oral microbiome. &#x02009;Following PPI administration (esomeprazole 20 mg, q.d., for 4 weeks), the abundance of <italic toggle="yes">Fusobacterium</italic> and <italic toggle="yes">Leptotrichia</italic> in the gingival crevicula fluid increasedand the abundance of <italic toggle="yes">Streptococcus</italic> in both saliva and periodontal pocket also increased but with no statistical significance, while <italic toggle="yes">Neisseria</italic> and <italic toggle="yes">Veillonella</italic> genera were significantly decrease in saliva [<xref rid="cit0066" ref-type="bibr">66</xref>]. Another similar study found that the abundance of <italic toggle="yes">Streptococcus</italic> in the gut microbiota increased following PPI administration (esomeprazole 40 mg q.d, 7&#x02009;days), and the increased <italic toggle="yes">Streptococcus</italic> originated from the oral or oral/nasal sites [<xref rid="cit0117" ref-type="bibr">117</xref>]. Compared with histamine 2 receptor antagonist, another gastric acid inhibitor, the use of PPIs resulted in significant increase of oral-to-intestinal transmission and promoted the growth of specific oral microorganisms in the gut [<xref rid="cit0118" ref-type="bibr">118</xref>]. PPIs modulate the gut microbiota by facilitating the translocation of oral-originated <italic toggle="yes">streptococci</italic> into the gut [<xref rid="cit0117" ref-type="bibr">117</xref>]. The alterations in the oral microbiota may be the direct effect of PPI (esomeprazole) that the saliva-secreted PPI may result in the Th2 immunity modification. Meanwhile the elevation of salivary pH resulting from the inhibitory effect of PPIs on gastroesophageal reflux may serves as another potential mechanisms [<xref rid="cit0066" ref-type="bibr">66</xref>]. PPIs are extensively utilized in the treatment of acid-related diseases, such as gastroesophageal reflux disease [<xref rid="cit0119" ref-type="bibr">119</xref>]. Patients with gastroesophageal reflux disease were excluded from the study [<xref rid="cit0066" ref-type="bibr">66</xref>]. It is noteworthy that <italic toggle="yes">H. pylori</italic> may be brought to the oral cavity via undetected gastroesophageal reflux, which could potentially lead to false-positive results in the detection of oral <italic toggle="yes">H. pylori</italic>. However, there is a lack of specific research investigating the correlation between gastroesophageal reflux and the detection rate of <italic toggle="yes">H. pylori</italic> in the oral cavity. However, in order to eliminate the impact of disease on the detection results, it is suggested that patients with such healthy problem should be excluded or taking samples at least two hours after reflux [<xref rid="cit0120" ref-type="bibr">120</xref>].</p><p>Research has found that bismuth-containing quadruple therapy can alter the composition of saliva microbiota. Most <italic toggle="yes">H. pylori</italic>-enriched genera, including <italic toggle="yes">Ralstonia, Leptotrichia, Sphingomonas, Leptothrix, Oribacterium</italic>, and <italic toggle="yes">Acinetobacter</italic> increased after eradication [<xref rid="cit0067" ref-type="bibr">67</xref>]. Although the precise mechanism that leads to the alteration has not been identified, a study provided evidence for the effect of bismuth on <italic toggle="yes">P. gingivalis</italic>, a pathogen highly associated with periodontitis. Bismuth disrupted the iron acquisition, interfered energy metabolism and virulence of the bacterium; and inactivate several key enzymes, such as superoxide dismutase and thioredoxin of <italic toggle="yes">P. gingivalis</italic>, while also inhibiting biofilm formation of the bacterium. Moreover, bismuth restored the downregulation of IL-1B and TNF gene mRNA expression caused by <italic toggle="yes">P. gingivalis</italic> in human gingival epithelial cells (HGECs) and helped maintain the viability of HGECs [<xref rid="cit0121" ref-type="bibr">121</xref>].</p><p>Vonoprazan (VPZ), a P-CAB, operates akin to PPIs by inhibiting gastric H, K-ATPase. However, unlike PPIs, P-CAB inhibits H, K-ATPase in a reversible and K-competitive manner. Compared with common PPIs, such as esomeprazole and rabeprazole, VPZ exhibits a quicker and more prolonged acid-suppressing effect [<xref rid="cit0122" ref-type="bibr">122</xref>]. Multiple clinical studies have demonstrated that VPZ and amoxicillin dual therapy (VA-dual) and VPZ, amoxicillin and clarithromycin triple therapy (VAC-triple) exhibit favorable efficacy among populations in China, Japan, and Western countries [<xref rid="cit0123" ref-type="bibr">123&#x02013;125</xref>]. Owing to the advantages of lower adverse effects and fewer antibiotic use in VA-dual therapy, this therapy was suggested as the first-line treatment for <italic toggle="yes">H. pylori</italic> infection [<xref rid="cit0124" ref-type="bibr">124</xref>]. Relevant studies have investigated the effects of VA-dual therapy on the oral microbiota. At the phylum level, the abundance of <italic toggle="yes">Firmicutes</italic> increased, while <italic toggle="yes">Proteobacteria</italic> and <italic toggle="yes">Verrucomicrobia</italic>. Neither high-dose VA-dual (H-VA, amoxicillin 1000&#x02009;mg t.i.d., VPZ20mg b.i.d.) treatment nor low-dose VA-dual (L-VA, amoxicillin 1000&#x02009;mg b.i.d., VPZ20mg b.i.d.) treatment altered the abundance, diversity, and uniformity of salivary flora. After VA-dual treatment, however, the decreased of <italic toggle="yes">Bacteroidetes</italic> and <italic toggle="yes">Firmicutes</italic> phylum was seen in L-VA-dual group and H-VA-dual, respectively, and the increased of <italic toggle="yes">Proteobacteria</italic> was seen in both groups [<xref rid="cit0068" ref-type="bibr">68</xref>]. Similarly to the study mentioned above, in terms of &#x003b1; diversity, higher diversity was found in the tongue coating flora of <italic toggle="yes">H. pylori</italic>-positive patients; but unlike the former mentioned study, no significant difference of the richness was showed between <italic toggle="yes">H. pylori</italic>-positive and <italic toggle="yes">H. pylori</italic>-negative [<xref rid="cit0126" ref-type="bibr">126</xref>]. In this study, VA dual therapy (amoxicillin 750&#x02009;mg q.i.d., VPZ20&#x02009;mg b.i.d., with Bifidobacterium tetravaccine tablets/placebo) influenced the microbiota diversity, structure and function. The supplementation of probiotics had no effect on the maintaining of oral microbiota during the eradication therapy. However, the proliferation of <italic toggle="yes">Firmicutes</italic> and <italic toggle="yes">Lactobacillus</italic> was suppressed by eradication therapy [<xref rid="cit0126" ref-type="bibr">126</xref>].</p><p>The eradication of <italic toggle="yes">H. pylori</italic> often involves the utilization of antibiotics [<xref rid="cit0116" ref-type="bibr">116</xref>]. The systemic application of antibiotics has an impact on the composition of the oral microbiota [<xref rid="cit0127" ref-type="bibr">127</xref>]. In clinical dental practice, amoxicillin and metronidazole are the most frequently prescribed antibiotics. Tetracycline, one of the antibiotic options in <italic toggle="yes">H. pylori</italic> eradication therapy, has been widely used but was reported exhibiting drug resistance in oral microbiota [<xref rid="cit0128" ref-type="bibr">128</xref>]; and it is reported a significantly positive correlation with the amount of <italic toggle="yes">Firmicutes</italic> in the subgingival flora [<xref rid="cit0127" ref-type="bibr">127</xref>]. Multidrug-resistant and tetracycline-resistant genes were identified in the subgingival microbiota, indicating that a broader and deeper analysis of antibiotic resistance in oral microbiota should be conducted [<xref rid="cit0128" ref-type="bibr">128</xref>]. The oral microbiota in different niches within the oral cavity serves as a reservoir of antibiotic resistance and genotypic analysis revealed tetracycline resistance as the most common form [<xref rid="cit0129" ref-type="bibr">129</xref>]. Long-term systemic antibiotics administration may have adverse impacts on the oral microbiota and periodontitis by inducing gut microbiota dysbiosis, possibly correlating with an imbalances of Th17/Treg [<xref rid="cit0130" ref-type="bibr">130</xref>]. The effects of antibiotics on the gut microbiota have been widely researched, but their influence on the oral microbiota is not extensively explored. The potential pathogenic risks associated with ectopic colonization of oral microorganisms are significant, as oral flora ectopic colonization may be a primary driving factor for gastric microbial dysbiosis in the process of gastric cancer [<xref rid="cit0131" ref-type="bibr">131</xref>]. Whether the ectopic colonization of antibiotic-resistant oral microbial communities impacts the equilibrium of the gut microbiota and the selection of systemic drug therapies is a subject that merits in-depth investigation in the future.</p><p><italic toggle="yes">H. pylori</italic> infection and eradication can lead to changes in the structure and composition of oral flora. Evidence suggests that after successful eradication, gastric microbial diversity significantly increases, and &#x003b1; diversity can be completely restored to the level of the uninfected control group [<xref rid="cit0132" ref-type="bibr">132</xref>]. Currently, there do not appear to be any studies on the recovery of oral microbiota after the eradication of <italic toggle="yes">H. pylori</italic>, and whether oral microbiology can be restored to pre-infected levels remains uncertain. Exploring the impact of medications used for <italic toggle="yes">H. pylori</italic> eradication on the oral microflora, and developing strategies to minimize their interference with oral microbial balance during treatment, represent potential directions for future research.</p></sec><sec disp-level="1" id="s0006"><title>Conclusion</title><p>The potential associations between various oral diseases and <italic toggle="yes">H. pylori</italic>, including dental caries, periodontitis, OLP, OSCC, and aphthous stomatitis were summarized. Evidence supported a positive correlation between <italic toggle="yes">H. pylori</italic> infection and these oral diseases. The failure of <italic toggle="yes">H. pylori</italic> eradication is correlated with the condition of dental caries, and a positive synergistic relationship between periodontal treatment and <italic toggle="yes">H. pylori</italic> eradication has been observed. The oral microbiota is influenced by the infection status of <italic toggle="yes">H. pylori</italic>. <italic toggle="yes">H. pylori</italic> can affect the oral microbiota through various potential mechanisms, including: <italic toggle="yes">H. pylori</italic> altering the diversity of the oral microbiota and reshaping its structure, as well as the varying virulence of <italic toggle="yes">H. pylori</italic> having different effects on the oral microbiota. In the context of different gastrointestinal diseases <italic toggle="yes">H. pylori</italic> also plays a role in altering the oral microbiota. <italic toggle="yes">H. pylori</italic> interacts with several pathogenic and opportunistic pathogens through multiple mechanisms, influencing the bacterial colonization and metabolism. <italic toggle="yes">H. pylori</italic> infection and eradication lead to alterations in the oral microbiota, both in composition and diversity. The medications used in eradication therapy can also impact the oral microbiota, and the emergence of drug-resistant bacteria warrants broader attention. <italic toggle="yes">H. pylori</italic> infection has a close and complex association with various oral diseases and the oral microbiota, yet many of the underlying mechanisms remain unclear. Future research should focus on unraveling these intrinsic connections and mechanisms to promote oral and overall health more effectively.</p></sec></body><back><sec sec-type="COI-statement" disp-level="1" id="s0007"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec disp-level="1" id="s0008"><title>Authors&#x02019; contributions</title><p>Conceptualization, Y.F., X.C., T.S., N.W., B.R. and L.C.; writing &#x02013; original draft preparation, Y.F., X.C. and L.C.; writing &#x02013; review and editing, B.R. and L.C.; visualization, Y.F. and X.C.; supervision, Q.H., L.C.; funding acquisition, X.C. and L.C.; All authors have read and agreed to the published version of the manuscript.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abdul</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Alkhelaiwi</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Alenazi</surname>
<given-names>AA</given-names></string-name>, et al</person-group>. <article-title>The association of Helicobacter Pylori in the oral cavity with dental caries in patients with and without gastric infection: a systematic review</article-title>. <source>Cureus</source>. <year>2023</year>;<volume>15</volume>(<issue>5</issue>). doi: <pub-id pub-id-type="doi">10.7759/cureus.38398</pub-id></mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tawfik</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Azab</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ramadan</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>The eradication of Helicobacter Pylori was significantly associated with compositional patterns of orointestinal axis microbiota</article-title>. <source>Pathog Basel Switz</source>. <year>2023</year>;<volume>12</volume>(<issue>6</issue>):<fpage>832</fpage>. doi: <pub-id pub-id-type="doi">10.3390/pathogens12060832</pub-id></mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kayali</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Manfredi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gaiani</surname>
<given-names>F</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori, transmission routes and recurrence of infection: state of the art</article-title>. <source>Acta Bio-Medica Atenei Parm</source>. <year>2018</year>;<volume>89</volume>(<issue>8&#x02013;S</issue>):<fpage>72</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crowe</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Solomon</surname>
<given-names>CG.</given-names></string-name></person-group>
<article-title><italic toggle="yes">Helicobacter Pylori</italic> infection</article-title>. <source>N Engl J Med</source>. <year>2019</year>;<volume>380</volume>(<issue>12</issue>):<fpage>1158</fpage>&#x02013;<lpage>1165</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMcp1710945</pub-id><pub-id pub-id-type="pmid">30893536</pub-id>
</mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beydoun</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Beydoun</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori, periodontal pathogens, and their interactive association with incident all-cause and alzheimer&#x02019;s disease dementia in a large national survey</article-title>. <source>Mol Psychiatry</source>. <year>2021</year>;<volume>26</volume>(<issue>10</issue>):<fpage>6038</fpage>&#x02013;<lpage>6053</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41380-020-0736-2</pub-id><pub-id pub-id-type="pmid">32366948</pub-id>
</mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iwai</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Azuma</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yonenaga</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Association between dental caries and Helicobacter Pylori infection in Japanese adults: a cross-sectional study</article-title>. <source>PLOS ONE</source>. <year>2022</year>;<volume>17</volume>(<issue>7</issue>):<fpage>e0271459</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0271459</pub-id><pub-id pub-id-type="pmid">35834591</pub-id>
</mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>HQ</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>The association between chronic periodontitis and oral Helicobacter Pylori: a meta-analysis</article-title>. <source>PLOS ONE</source>. <year>2019</year>;<volume>14</volume>(<issue>12</issue>):<fpage>e0225247</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0225247</pub-id><pub-id pub-id-type="pmid">31825954</pub-id>
</mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>Z</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori infection is correlated with the incidence of erosive oral lichen planus and the alteration of the oral microbiome composition</article-title>. <source>BMC Microbiol</source>. <year>2021</year>;<volume>21</volume>(<issue>1</issue>):<fpage>122</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12866-021-02188-0</pub-id><pub-id pub-id-type="pmid">33879055</pub-id>
</mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kannan</surname>
<given-names>N</given-names></string-name></person-group>. <article-title>Helicobacter Pylori positive oral squamous cell carcinoma demonstrate higher pathological tumor staging and poorer overall survival</article-title>. <source>J Stomatol Oral Maxillofac Surg</source>. <year>2024</year>;<volume>125</volume>(<issue>4</issue>):<fpage>101952</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jormas.2024.101952</pub-id><pub-id pub-id-type="pmid">38906379</pub-id>
</mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kitamoto</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nagao-Kitamoto</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hein</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>The bacterial connection between the oral cavity and the gut diseases</article-title>. <source>J Dent Res</source>. <year>2020</year>;<volume>99</volume>(<issue>9</issue>):<fpage>1021</fpage>&#x02013;<lpage>1029</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0022034520924633</pub-id><pub-id pub-id-type="pmid">32464078</pub-id>
</mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>The interactions between oral-gut axis microbiota and Helicobacter Pylori</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2022</year>;<volume>12</volume>:<fpage>914418</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2022.914418</pub-id><pub-id pub-id-type="pmid">35992177</pub-id>
</mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brown</surname>
<given-names>LM</given-names></string-name></person-group>. <article-title>Helicobacter Pylori: epidemiology and routes of transmission</article-title>. <source>Epidemiol Rev</source>. <year>2000</year>;<volume>22</volume>(<issue>2</issue>):<fpage>283</fpage>&#x02013;<lpage>297</lpage>. doi: <pub-id pub-id-type="doi">10.1093/oxfordjournals.epirev.a018040</pub-id><pub-id pub-id-type="pmid">11218379</pub-id>
</mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rasmussen</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Labio</surname>
<given-names>RWD</given-names></string-name>, <string-name><surname>Gatti</surname>
<given-names>LL</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori detection in gastric biopsies, saliva and dental plaque of Brazilian dyspeptic patients</article-title>. <source>Mem Inst Oswaldo Cruz</source>. <year>2010</year>;<volume>105</volume>(<issue>3</issue>):<fpage>326</fpage>&#x02013;<lpage>330</lpage>. doi: <pub-id pub-id-type="doi">10.1590/S0074-02762010000300015</pub-id><pub-id pub-id-type="pmid">20512249</pub-id>
</mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>El Batawi</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Venkatachalam</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Francis</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Dental caries&#x02013;a hiding niche for Helicobacter Pylori in children</article-title>. <source>J Clin Pediatr Dent</source>. <year>2020</year>;<volume>44</volume>(<issue>2</issue>):<fpage>90</fpage>&#x02013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.17796/1053-4625-44.2.4</pub-id><pub-id pub-id-type="pmid">32271664</pub-id>
</mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nomura</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ogaya</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Matayoshi</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Molecular and clinical analyses of Helicobacter Pylori colonization in inflamed dental pulp</article-title>. <source>BMC Oral Health</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>64</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12903-018-0526-2</pub-id><pub-id pub-id-type="pmid">29661188</pub-id>
</mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iwai</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Watanabe</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Yamamoto</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Association between Helicobacter Pylori infection and dental pulp reservoirs in Japanese adults</article-title>. <source>BMC Oral Health</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>267</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12903-019-0967-2</pub-id><pub-id pub-id-type="pmid">31791309</pub-id>
</mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>B</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori in the oral cavity: current evidence and potential survival strategies</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>21</issue>):<fpage>13646</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms232113646</pub-id><pub-id pub-id-type="pmid">36362445</pub-id>
</mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mathur</surname>
<given-names>VP</given-names></string-name>, <string-name><surname>Dhillon</surname>
<given-names>JK</given-names></string-name></person-group>. <article-title>Dental caries: a disease which needs attention</article-title>. <source>Indian J Pediatr</source>. <year>2018</year>;<volume>85</volume>(<issue>3</issue>):<fpage>202</fpage>&#x02013;<lpage>206</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12098-017-2381-6</pub-id><pub-id pub-id-type="pmid">28643162</pub-id>
</mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sruthi</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Mani</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ramakrishnan</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Dental caries as a source of Helicobacter Pylori infection in children: an RT&#x02010;PCR study</article-title>. <source>Int J Paediatr Dent</source>. <year>2023</year>;<volume>33</volume>(<issue>1</issue>):<fpage>82</fpage>&#x02013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ipd.13017</pub-id><pub-id pub-id-type="pmid">35771167</pub-id>
</mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Study on the relationship between <italic toggle="yes">Helicobacter Pylori</italic> in the dental plaque and the occurrence of dental caries or oral hygiene index</article-title>. <source>Helicobacter</source>. <year>2008</year>;<volume>13</volume>(<issue>4</issue>):<fpage>256</fpage>&#x02013;<lpage>260</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1523-5378.2008.00602.x</pub-id><pub-id pub-id-type="pmid">18665933</pub-id>
</mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ding</surname>
<given-names>Y-J</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>T-L</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>X-L</given-names></string-name>, et al</person-group>. <article-title>Association of salivary Helicobacter Pylori infection with oral diseases: a cross-sectional study in a Chinese population</article-title>. <source>Int J Med Sci</source>. <year>2015</year>;<volume>12</volume>(<issue>9</issue>):<fpage>742</fpage>&#x02013;<lpage>747</lpage>. doi: <pub-id pub-id-type="doi">10.7150/ijms.11050</pub-id><pub-id pub-id-type="pmid">26392812</pub-id>
</mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iwai</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Azuma</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Yonenaga</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Association between failed eradication of 7-day triple therapy for Helicobacter Pylori and untreated dental caries in Japanese adults</article-title>. <source>Sci Rep</source>. <year>2024</year>;<volume>14</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1038/s41598-024-54757-8</pub-id></mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slots</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Periodontitis: facts, fallacies and the future</article-title>. <source>Periodontol 2000</source>. <year>2017</year>;<volume>75</volume>(<issue>1</issue>):<fpage>7</fpage>&#x02013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1111/prd.12221</pub-id><pub-id pub-id-type="pmid">28758294</pub-id>
</mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moradi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Majidi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Khateri</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>The association between periodontal diseases and Helicobacter Pylori: an updated meta-analysis of observational studies</article-title>. <source>BMC Oral Health</source>. <year>2023</year>;<volume>23</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1186/s12903-023-03232-3</pub-id></mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Larsson</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Kavanagh</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>TVN</given-names></string-name>, et al</person-group>. <article-title>Influence of epigenetics on periodontitis and peri-implantitis pathogenesis</article-title>. <source>Periodontol 2000</source>. <year>2022</year>;<volume>90</volume>(<issue>1</issue>):<fpage>125</fpage>&#x02013;<lpage>137</lpage>. doi: <pub-id pub-id-type="doi">10.1111/prd.12453</pub-id><pub-id pub-id-type="pmid">35913702</pub-id>
</mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schulz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Immel</surname>
<given-names>UD</given-names></string-name>, <string-name><surname>Just</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Epigenetic characteristics in inflammatory Candidate genes in aggressive periodontitis</article-title>. <source>Hum Immunol</source>. <year>2016</year>;<volume>77</volume>(<issue>1</issue>):<fpage>71</fpage>&#x02013;<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.humimm.2015.10.007</pub-id><pub-id pub-id-type="pmid">26472015</pub-id>
</mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Luzza</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Parrello</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Monteleone</surname>
<given-names>G</given-names></string-name>, et al</person-group>. <article-title>Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter Pylori-infected human gastric mucosa</article-title>. <source>J Immunol Baltim Md 1950</source>. <year>2000</year>;<volume>165</volume>(<issue>9</issue>):<fpage>5332</fpage>&#x02013;<lpage>5337</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.165.9.5332</pub-id></mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shiota</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Yamaoka</surname>
<given-names>Y</given-names></string-name></person-group>. <article-title>The significance of virulence factors in Helicobacter Pylori</article-title>. <source>J Dig Dis</source>. <year>2013</year>;<volume>14</volume>(<issue>7</issue>):<fpage>341</fpage>&#x02013;<lpage>349</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1751-2980.12054</pub-id><pub-id pub-id-type="pmid">23452293</pub-id>
</mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>Q</given-names></string-name>, et al</person-group>. <article-title>Association between the presence and genotype of Helicobacter Pylori and periodontitis</article-title>. <source>Exp Ther Med</source>. <year>2023</year>;<volume>26</volume>(<issue>4</issue>). doi: <pub-id pub-id-type="doi">10.3892/etm.2023.12188</pub-id></mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flores-Trevi&#x000f1;o</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Urrutia-Baca</surname>
<given-names>VH</given-names></string-name>, <string-name><surname>G&#x000f3;mez-Flores</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>Molecular detection of Helicobacter Pylori based on the presence of cagA and vacA virulence genes in dental plaque from patients with periodontitis</article-title>. <source>J Dent Sci</source>. <year>2019</year>;<volume>14</volume>(<issue>2</issue>):<fpage>163</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jds.2019.01.010</pub-id><pub-id pub-id-type="pmid">31210890</pub-id>
</mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tsimpiris</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Grigoriadis</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tsolianos</surname>
<given-names>I</given-names></string-name>, et al</person-group>. <article-title>Periodontitis and Helicobacter Pylori infection: eradication and periodontal therapy combination</article-title>. <source>Eur J Dent</source>. <year>2022</year>;<volume>16</volume>(<issue>1</issue>):<fpage>145</fpage>&#x02013;<lpage>152</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0041-1731928</pub-id><pub-id pub-id-type="pmid">34598295</pub-id>
</mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bouziane</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ahid</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Abouqal</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>Effect of periodontal therapy on prevention of gastric Helicobacter Pylori recurrence: a systematic review and meta-analysis</article-title>. <source>J Clin Periodontol</source>. <year>2012</year>;<volume>39</volume>(<issue>12</issue>):<fpage>1166</fpage>&#x02013;<lpage>1173</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jcpe.12015</pub-id><pub-id pub-id-type="pmid">23151293</pub-id>
</mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ps</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kp</surname>
<given-names>K</given-names></string-name>, <string-name><surname>S</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Role of dental plaque, saliva and periodontal disease in Helicobacter pylori infection</article-title>. <source>World J Gastroenterol</source>. <year>2014</year>;<volume>20</volume>(<issue>19</issue>):<fpage>5639</fpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v20.i19.5639</pub-id><pub-id pub-id-type="pmid">24914323</pub-id>
</mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dioguardi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Crincoli</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Laino</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>The role of periodontitis and periodontal bacteria in the onset and progression of alzheimer&#x02019;s disease: a systematic review</article-title>. <source>J Clin Med</source>. <year>2020</year>;<volume>9</volume>(<issue>2</issue>):<fpage>495</fpage>. doi: <pub-id pub-id-type="doi">10.3390/jcm9020495</pub-id><pub-id pub-id-type="pmid">32054121</pub-id>
</mixed-citation></ref><ref id="cit0035"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Douros</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ante</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Fallone</surname>
<given-names>CA</given-names></string-name>, et al</person-group>. <article-title>Clinically apparent Helicobacter pylori infection and the risk of incident alzheimer&#x02019;s disease: a population-based nested case-control study</article-title>. <source>Alzheimers Dement J Alzheimers Assoc</source>. <year>2024</year>;<volume>20</volume>(<issue>3</issue>):<fpage>1716</fpage>&#x02013;<lpage>1724</lpage>. doi: <pub-id pub-id-type="doi">10.1002/alz.13561</pub-id></mixed-citation></ref><ref id="cit0036"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poole</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Singhrao</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Kesavalu</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Determining the presence of periodontopathic virulence factors in short-term postmortem alzheimer&#x02019;s disease brain tissue</article-title>. <source>J Alzheimers Dis</source>. <year>2013</year>;<volume>36</volume>(<issue>4</issue>):<fpage>665</fpage>&#x02013;<lpage>677</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-121918</pub-id><pub-id pub-id-type="pmid">23666172</pub-id>
</mixed-citation></ref><ref id="cit0037"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lane</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Hardy</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Schott</surname>
<given-names>JM</given-names></string-name></person-group>. <article-title>Alzheimer&#x02019;s Disease</article-title>. <source>Eur J Neurol</source>. <year>2018</year>;<volume>25</volume>(<issue>1</issue>):<fpage>59</fpage>&#x02013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ene.13439</pub-id><pub-id pub-id-type="pmid">28872215</pub-id>
</mixed-citation></ref><ref id="cit0038"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Research progress on Helicobacter Pylori infection related neurological diseases</article-title>. <source>Ageing Res Rev</source>. <year>2024</year>;<volume>99</volume>:<fpage>102399</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2024.102399</pub-id><pub-id pub-id-type="pmid">38955263</pub-id>
</mixed-citation></ref><ref id="cit0039"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boziki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Polyzos</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Deretzi</surname>
<given-names>G</given-names></string-name>, et al</person-group>. <article-title>A potential impact of Helicobacter Pylori-related galectin-3 in neurodegeneration</article-title>. <source>Neurochem Int</source>. <year>2018</year>;<volume>113</volume>:<fpage>137</fpage>&#x02013;<lpage>151</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuint.2017.12.003</pub-id><pub-id pub-id-type="pmid">29246761</pub-id>
</mixed-citation></ref><ref id="cit0040"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uberti</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Callai-Silva</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Grahl</surname>
<given-names>MVC</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori Urease: potential contributions to alzheimer&#x02019;s disease</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>6</issue>):<fpage>3091</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms23063091</pub-id><pub-id pub-id-type="pmid">35328512</pub-id>
</mixed-citation></ref><ref id="cit0041"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cools</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Van Imschoot</surname>
<given-names>G</given-names></string-name>, et al</person-group>. <article-title>Helicobacter pylori -derived outer membrane vesicles contribute to alzheimer&#x02019;s disease pathogenesis via C3-C3aR signalling</article-title>. <source>J Extracell Vesicles</source>. <year>2023</year>;<volume>12</volume>(<issue>2</issue>):<fpage>e12306</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jev2.12306</pub-id><pub-id pub-id-type="pmid">36792546</pub-id>
</mixed-citation></ref><ref id="cit0042"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meng</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori outer membrane vesicles directly promote A&#x003b2; aggregation and enhance A&#x003b2; toxicity in APP/PS1 mice</article-title>. <source>Commun Biol</source>. <year>2024</year>;<volume>7</volume>(<issue>1</issue>):<fpage>1474</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s42003-024-07125-1</pub-id><pub-id pub-id-type="pmid">39516239</pub-id>
</mixed-citation></ref><ref id="cit0043"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kandpal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Baral</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Varshney</surname>
<given-names>N</given-names></string-name>, et al</person-group>. <article-title>Gut-brain axis interplay via STAT3 pathway: implications of Helicobacter Pylori derived secretome on inflammation and alzheimer&#x02019;s disease</article-title>. <source>Virulence</source>. <year>2024</year>;<volume>15</volume>(<issue>1</issue>):<fpage>2303853</fpage>. doi: <pub-id pub-id-type="doi">10.1080/21505594.2024.2303853</pub-id><pub-id pub-id-type="pmid">38197252</pub-id>
</mixed-citation></ref><ref id="cit0044"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ku&#x0017a;niar</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kozubek</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Czaja</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Correlation between alzheimer&#x02019;s disease and gastrointestinal tract disorders</article-title>. <source>Nutrients</source>. <year>2024</year>;<volume>16</volume>(<issue>14</issue>):<fpage>2366</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu16142366</pub-id><pub-id pub-id-type="pmid">39064809</pub-id>
</mixed-citation></ref><ref id="cit0045"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liccardo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Marzano</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Carraturo</surname>
<given-names>F</given-names></string-name>, et al</person-group>. <article-title>Potential bidirectional relationship between periodontitis and alzheimer&#x02019;s disease</article-title>. <source>Front Physiol</source>. <year>2020</year>;<volume>11</volume>:<fpage>683</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2020.00683</pub-id><pub-id pub-id-type="pmid">32719612</pub-id>
</mixed-citation></ref><ref id="cit0046"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dominy</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Lynch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ermini</surname>
<given-names>F</given-names></string-name>, et al</person-group>. <article-title>Porphyromonas Gingivalis in alzheimer&#x02019;s disease brains: evidence for disease causation and treatment with small-molecule inhibitors</article-title>. <source>Sci Adv</source>. <year>2019</year>;<volume>5</volume>(<issue>1</issue>):<fpage>eaau3333</fpage>. doi: <pub-id pub-id-type="doi">10.1126/sciadv.aau3333</pub-id><pub-id pub-id-type="pmid">30746447</pub-id>
</mixed-citation></ref><ref id="cit0047"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ide</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Harris</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Stevens</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Periodontitis and cognitive decline in alzheimer&#x02019;s disease</article-title>. <source>PLOS ONE</source>. <year>2016</year>;<volume>11</volume>(<issue>3</issue>):<fpage>e0151081</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0151081</pub-id><pub-id pub-id-type="pmid">26963387</pub-id>
</mixed-citation></ref><ref id="cit0048"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hamour</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Klieb</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Eskander</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Oral lichen planus</article-title>. <source>CMAJ Can Med Assoc J</source>. <year>2020</year>;<volume>192</volume>(<issue>31</issue>):<fpage>E892</fpage>. doi: <pub-id pub-id-type="doi">10.1503/cmaj.200309</pub-id><pub-id pub-id-type="pmid">32753462</pub-id>
</mixed-citation></ref><ref id="cit0049"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Attia</surname>
<given-names>EAS</given-names></string-name>, <string-name><surname>Abdel Fattah</surname>
<given-names>NSA</given-names></string-name>, <string-name><surname>Abdella</surname>
<given-names>HM</given-names></string-name></person-group>. <article-title>Upper gastrointestinal findings and detection of Helicobacter Pylori in patients with oral lichen planus</article-title>. <source>Clin Exp Dermatol</source>. <year>2010</year>;<volume>35</volume>(<issue>4</issue>):<fpage>355</fpage>&#x02013;<lpage>360</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2230.2009.03464.x</pub-id><pub-id pub-id-type="pmid">19663844</pub-id>
</mixed-citation></ref><ref id="cit0050"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>M&#x000e9;graud</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lehours</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Helicobacter Pylori detection and antimicrobial susceptibility testing</article-title>. <source>Clin Microbiol Rev</source>. <year>2007</year>;<volume>20</volume>(<issue>2</issue>):<fpage>280</fpage>&#x02013;<lpage>322</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00033-06</pub-id><pub-id pub-id-type="pmid">17428887</pub-id>
</mixed-citation></ref><ref id="cit0051"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chua</surname>
<given-names>E-G</given-names></string-name>, <string-name><surname>Chong</surname>
<given-names>J-Y</given-names></string-name>, <string-name><surname>Lamichhane</surname>
<given-names>B</given-names></string-name>, et al</person-group>. <article-title>Gastric Helicobacter Pylori infection perturbs human oral microbiota</article-title>. <source>PeerJ</source>. <year>2019</year>;<volume>7</volume>:<fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.7717/peerj.6336</pub-id></mixed-citation></ref><ref id="cit0052"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chamoli</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics</article-title>. <source>Oral Oncol</source>. <year>2021</year>;<volume>121</volume>:<fpage>2021</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.oraloncology.2021.105451</pub-id></mixed-citation></ref><ref id="cit0053"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pandey</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Follin-Arbelet</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Pun</surname>
<given-names>CB</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori was not detected in oral squamous cell carcinomas from cohorts of Norwegian and Nepalese patients</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>8737</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-65694-7</pub-id><pub-id pub-id-type="pmid">32457404</pub-id>
</mixed-citation></ref><ref id="cit0054"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>He</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>An inverse association of Helicobacter Pylori infection with oral squamous cell carcinoma</article-title>. <source>J Oral Pathol Med</source>. <year>2016</year>;<volume>45</volume>(<issue>1</issue>):<fpage>17</fpage>&#x02013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jop.12324</pub-id><pub-id pub-id-type="pmid">25899621</pub-id>
</mixed-citation></ref><ref id="cit0055"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gomes</surname>
<given-names>C-C</given-names></string-name>, <string-name><surname>Gomez</surname>
<given-names>R-S</given-names></string-name>, <string-name><surname>Zina</surname>
<given-names>L-G</given-names></string-name>, et al</person-group>. <article-title>Recurrent aphthous stomatitis and Helicobacter Pylori</article-title>. <source>Med Oral Patol Oral Cirugia Bucal</source>. <year>2016</year>;<volume>21</volume>(<issue>2</issue>):<fpage>e187</fpage>&#x02013;<lpage>191</lpage>. doi: <pub-id pub-id-type="doi">10.4317/medoral.20872</pub-id></mixed-citation></ref><ref id="cit0056"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karaca</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Seyhan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Senol</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>The effect of gastric <italic toggle="yes">Helicobacter Pylori</italic> eradication on recurrent aphthous stomatitis</article-title>. <source>Int J Dermatol</source>. <year>2008</year>;<volume>47</volume>(<issue>6</issue>):<fpage>615</fpage>&#x02013;<lpage>617</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-4632.2008.03667.x</pub-id><pub-id pub-id-type="pmid">18477159</pub-id>
</mixed-citation></ref><ref id="cit0057"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Albanidou-Farmaki</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Giannoulis</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Markopoulos</surname>
<given-names>A</given-names></string-name></person-group>, et al. <article-title>Outcome following treatment for Helicobacter Pylori in patients with recurrent aphthous stomatitis</article-title>. <source>Oral Dis</source>. <year>2005</year>;<volume>11</volume>(<issue>1</issue>): <fpage>22</fpage>&#x02013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1601-0825.2004.01053.x</pub-id><pub-id pub-id-type="pmid">15641963</pub-id>
</mixed-citation></ref><ref id="cit0058"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Is Helicobacter pylori associated with Beh&#x000e7;et&#x02019;s syndrome? A meta-analysis</article-title>. <source>Helicobacter</source>. <year>2019</year>;<volume>24</volume>(<issue>6</issue>). doi: <pub-id pub-id-type="doi">10.1111/hel.12663</pub-id></mixed-citation></ref><ref id="cit0059"><label>[59]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Apan</surname>
<given-names>TZ</given-names></string-name>, <string-name><surname>G&#x000fc;rsel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Dolgun</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Increased seropositivity of Helicobacter Pylori cytotoxin-associated gene-A in Beh&#x000e7;et&#x02019;s disease</article-title>. <source>Clin Rheumatol</source>. <year>2007</year>;<volume>26</volume>(<issue>6</issue>):<fpage>885</fpage>&#x02013;<lpage>889</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10067-006-0416-x</pub-id><pub-id pub-id-type="pmid">17021670</pub-id>
</mixed-citation></ref><ref id="cit0060"><label>[60]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Avc&#x00131;</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Ellidokuz</surname>
<given-names>E</given-names></string-name>, <string-name><surname>&#x0015e;im&#x0015f;ek</surname>
<given-names>I</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Helicobacter Pylori</italic> and Beh&#x000e7;et&#x02019;s disease</article-title>. <source>Dermatology</source>. <year>1999</year>;<volume>199</volume>(<issue>2</issue>):<fpage>140</fpage>&#x02013;<lpage>143</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000018221</pub-id><pub-id pub-id-type="pmid">10559580</pub-id>
</mixed-citation></ref><ref id="cit0061"><label>[61]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>Y-K</given-names></string-name>, <string-name><surname>Kuo</surname>
<given-names>F-C</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>C-J</given-names></string-name>, et al</person-group>. <article-title>Diagnosis of Helicobacter Pylori infection: current options and developments</article-title>. <source>World J Gastroenterol</source>. <year>2015</year>;<volume>21</volume>(<issue>40</issue>):<fpage>11221</fpage>&#x02013;<lpage>11235</lpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v21.i40.11221</pub-id><pub-id pub-id-type="pmid">26523098</pub-id>
</mixed-citation></ref><ref id="cit0062"><label>[62]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Williams</surname>
<given-names>CL</given-names></string-name></person-group>. <article-title><italic toggle="yes">Helicobacter Pylori</italic>: bacteriology and laboratory diagnosis</article-title>. <source>J Infect</source>. <year>1997</year>;<volume>34</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0163-4453(97)80002-3</pub-id><pub-id pub-id-type="pmid">9120318</pub-id>
</mixed-citation></ref><ref id="cit0063"><label>[63]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagata</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ohsumi</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Takenaka</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Current prevalence of oral Helicobacter Pylori among Japanese adults determined using a nested polymerase chain reaction assay</article-title>. <source>Pathogens</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.3390/pathogens10010010</pub-id><pub-id pub-id-type="pmid">33374353</pub-id>
</mixed-citation></ref><ref id="cit0064"><label>[64]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title>Human oral microbiota and its modulation for oral health</article-title>. <source>Biomed Pharmacother</source>. <year>2018</year>;<volume>99</volume>:<fpage>883</fpage>&#x02013;<lpage>893</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2018.01.146</pub-id><pub-id pub-id-type="pmid">29710488</pub-id>
</mixed-citation></ref><ref id="cit0065"><label>[65]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tuominen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Rautava</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Oral microbiota and cancer development</article-title>. <source>Pathobiology</source>. <year>2021</year>;<volume>88</volume>(<issue>2</issue>):<fpage>116</fpage>&#x02013;<lpage>126</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000510979</pub-id><pub-id pub-id-type="pmid">33176328</pub-id>
</mixed-citation></ref><ref id="cit0066"><label>[66]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mishiro</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Oka</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kuroki</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Oral microbiome alterations of healthy volunteers with proton pump inhibitor</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2018</year>;<volume>33</volume>(<issue>5</issue>):<fpage>1059</fpage>&#x02013;<lpage>1066</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jgh.14040</pub-id><pub-id pub-id-type="pmid">29105152</pub-id>
</mixed-citation></ref><ref id="cit0067"><label>[67]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ji</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Analysis of by high-throughput sequencing: Helicobacter Pylori infection and salivary microbiome</article-title>. <source>BMC Oral Health</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>20</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12903-020-01070-1</pub-id><pub-id pub-id-type="pmid">31973720</pub-id>
</mixed-citation></ref><ref id="cit0068"><label>[68]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ouyang</surname>
<given-names>YB</given-names></string-name>, et al</person-group>. <article-title>Analysis of oral microbiota alterations induced by Helicobacter Pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter Pylori eradication</article-title>. <source>Helicobacter</source>. <year>2022</year>;<volume>27</volume>(<issue>5</issue>). doi: <pub-id pub-id-type="doi">10.1111/hel.12923</pub-id></mixed-citation></ref><ref id="cit0069"><label>[69]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Knorr</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ricci</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Hatakeyama</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Classification of <italic toggle="yes">Helicobacter Pylori</italic> virulence factors: Is CagA a toxin or not?</article-title>. <source>Trends Microbiol</source>. <year>2019</year>;<volume>27</volume>(<issue>9</issue>):<fpage>731</fpage>&#x02013;<lpage>738</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2019.04.010</pub-id><pub-id pub-id-type="pmid">31130493</pub-id>
</mixed-citation></ref><ref id="cit0070"><label>[70]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori infection alters gastric and tongue coating microbial communities</article-title>. <source>Helicobacter</source>. <year>2019</year>;<volume>24</volume>(<issue>2</issue>). doi: <pub-id pub-id-type="doi">10.1111/hel.12567</pub-id></mixed-citation></ref><ref id="cit0071"><label>[71]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hua</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori infection altered gastric microbiota in patients with chronic gastritis</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2023</year>;<volume>13</volume>:<fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2023.1221433</pub-id></mixed-citation></ref><ref id="cit0072"><label>[72]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Effects of Helicobacter Pylori infection on the oral microbiota of reflux esophagitis patients</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2021</year>;<volume>11</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2021.732613</pub-id></mixed-citation></ref><ref id="cit0073"><label>[73]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>CH</given-names></string-name>, et al</person-group>. <article-title>Roles of streptococcus mutans in human health: beyond dental caries</article-title>. <source>Front Microbiol</source>. <year>2024</year>;<volume>15</volume>:<fpage>1503657</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2024.1503657</pub-id><pub-id pub-id-type="pmid">39749137</pub-id>
</mixed-citation></ref><ref id="cit0074"><label>[74]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>New strategies and mechanisms for targeting streptococcus mutans biofilm formation to prevent dental caries: a review</article-title>. <source>Microbiol Res</source>. <year>2023</year>;<volume>278</volume>:<fpage>127526</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micres.2023.127526</pub-id><pub-id pub-id-type="pmid">39491258</pub-id>
</mixed-citation></ref><ref id="cit0075"><label>[75]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nomura</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kadota</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ogaya</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Contribution of streptococcus mutans to Helicobacter Pylori colonisation in oral cavity and gastric tissue</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-69368-2</pub-id><pub-id pub-id-type="pmid">32001736</pub-id>
</mixed-citation></ref><ref id="cit0076"><label>[76]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>X</given-names></string-name>, et al</person-group>. <article-title>Influence of Helicobacter Pylori culture supernatant on the ecological balance of a dual-species oral biofilm</article-title>. <source>J Appl Oral Sci Rev FOB</source>. <year>2018</year>;<volume>26</volume>(<issue>0</issue>):<fpage>e20170113</fpage>. doi: <pub-id pub-id-type="doi">10.1590/1678-7757-2017-0113</pub-id></mixed-citation></ref><ref id="cit0077"><label>[77]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mitchell</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Streptococcus Mitis: walking the line between commensalism and pathogenesis</article-title>. <source>Mol Oral Microbiol</source>. <year>2011</year>;<volume>26</volume>(<issue>2</issue>):<fpage>89</fpage>&#x02013;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.2041-1014.2010.00601.x</pub-id><pub-id pub-id-type="pmid">21375700</pub-id>
</mixed-citation></ref><ref id="cit0078"><label>[78]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khosravi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dieye</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Loke</surname>
<given-names>MF</given-names></string-name>, et al</person-group>. <article-title>Streptococcus mitis induces conversion of Helicobacter Pylori to coccoid cells during Co-culture in vitro</article-title>. <source>PLOS ONE</source>. <year>2014</year>;<volume>9</volume>(<issue>11</issue>):<fpage>e112214</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0112214</pub-id><pub-id pub-id-type="pmid">25386948</pub-id>
</mixed-citation></ref><ref id="cit0079"><label>[79]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khosravi</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Loke</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Goh</surname>
<given-names>KL</given-names></string-name>, et al</person-group>. <article-title>Proteomics analysis revealed that crosstalk between Helicobacter Pylori and streptococcus mitis may enhance bacterial survival and reduces carcinogenesis</article-title>. <source>Front Microbiol</source>. <year>2016</year>;<volume>7</volume>:<fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2016.01462</pub-id><pub-id pub-id-type="pmid">26858696</pub-id>
</mixed-citation></ref><ref id="cit0080"><label>[80]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okuda</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ishihara</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Miura</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori May have only a transient presence in the oral cavity and on the surface of oral cancer</article-title>. <source>Microbiol Immunol</source>. <year>2000</year>;<volume>44</volume>(<issue>5</issue>):<fpage>385</fpage>&#x02013;<lpage>388</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1348-0421.2000.tb02510.x</pub-id><pub-id pub-id-type="pmid">10888357</pub-id>
</mixed-citation></ref><ref id="cit0081"><label>[81]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ishihara</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Miura</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kimizuka</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>Oral bacteria inhibit Helicobacter Pylori growth</article-title>. <source>FEMS Microbiol Lett</source>. <year>1997</year>;<volume>152</volume>(<issue>2</issue>):<fpage>355</fpage>&#x02013;<lpage>361</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0378-1097(97)00227-9</pub-id><pub-id pub-id-type="pmid">9231428</pub-id>
</mixed-citation></ref><ref id="cit0082"><label>[82]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mysak</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Podzimek</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sommerova</surname>
<given-names>P</given-names></string-name>, et al</person-group>. <article-title>Porphyromonas Gingivalis: major Periodontopathic Pathogen Overview</article-title>. <source>J Immunol Res</source>. <year>2014</year>;<volume>2014</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2014/476068</pub-id></mixed-citation></ref><ref id="cit0083"><label>[83]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Q</given-names></string-name>, et al</person-group>. <article-title>The effect of the &#x0201c;oral-gut&#x0201d; axis on periodontitis in inflammatory bowel disease: a review of microbe and immune mechanism associations</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2023</year>;<volume>13</volume>:<fpage>1132420</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2023.1132420</pub-id><pub-id pub-id-type="pmid">36923589</pub-id>
</mixed-citation></ref><ref id="cit0084"><label>[84]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soto</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rojas</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Y&#x000e1;&#x000f1;ez</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Porphyromonas gingivalis-Helicobacter Pylori Co-incubation enhances porphyromonas gingivalis virulence and increases migration of infected human oral keratinocytes</article-title>. <source>J Oral Microbiol</source>. <year>2022</year>;<volume>14</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.1080/20002297.2022.2107691</pub-id></mixed-citation></ref><ref id="cit0085"><label>[85]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Larussa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Leone</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Suraci</surname>
<given-names>E</given-names></string-name>, et al</person-group>. <article-title>Enhanced expression of indoleamine 2,3&#x02010;dioxygenase in Helicobacter pylori&#x02010;infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production</article-title>. <source>Gastroenterology</source>. <year>2014</year>;<volume>146</volume>(<issue>5</issue>):<fpage>S</fpage>&#x02013;<lpage>504</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0016-5085(14)61819-9</pub-id></mixed-citation></ref><ref id="cit0086"><label>[86]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bunte</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Beikler</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases</article-title>. <source>Int J Mol Sci</source>. <year>2019</year>;<volume>20</volume>(<issue>14</issue>):<fpage>3394</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms20143394</pub-id><pub-id pub-id-type="pmid">31295952</pub-id>
</mixed-citation></ref><ref id="cit0087"><label>[87]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hajishengallis</surname>
<given-names>G</given-names></string-name></person-group>. <article-title>Periodontitis: from microbial immune subversion to systemic inflammation</article-title>. <source>Nat Rev Immunol</source>. <year>2015</year>;<volume>15</volume>(<issue>1</issue>):<fpage>30</fpage>&#x02013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nri3785</pub-id><pub-id pub-id-type="pmid">25534621</pub-id>
</mixed-citation></ref><ref id="cit0088"><label>[88]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagano</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Abiko</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yoshida</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Genetic and antigenic analyses of porphyromonas gingivalis FimA fimbriae</article-title>. <source>Mol Oral Microbiol</source>. <year>2013</year>;<volume>28</volume>(<issue>5</issue>):<fpage>392</fpage>&#x02013;<lpage>403</lpage>. doi: <pub-id pub-id-type="doi">10.1111/omi.12032</pub-id><pub-id pub-id-type="pmid">23809984</pub-id>
</mixed-citation></ref><ref id="cit0089"><label>[89]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Differential expression and adherence of porphyromonas gingivalis FimA genotypes</article-title>. <source>Mol Oral Microbiol</source>. <year>2011</year>;<volume>26</volume>(<issue>6</issue>):<fpage>388</fpage>&#x02013;<lpage>395</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.2041-1014.2011.00626.x</pub-id><pub-id pub-id-type="pmid">22053966</pub-id>
</mixed-citation></ref><ref id="cit0090"><label>[90]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kadota</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hamada</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nomura</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>Distribution of Helicobacter Pylori and periodontopathic bacterial species in the oral cavity</article-title>. <source>Biomedicines</source>. <year>2020</year>;<volume>8</volume>(<issue>6</issue>):<fpage>161</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biomedicines8060161</pub-id><pub-id pub-id-type="pmid">32549275</pub-id>
</mixed-citation></ref><ref id="cit0091"><label>[91]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>W</given-names></string-name>, et al</person-group>. <article-title>The prevalence of fimA genotypes of porphyromonas gingivalis in patients with chronic periodontitis: a meta-analysis</article-title>. <source>PLOS ONE</source>. <year>2020</year>;<volume>15</volume>(<issue>10</issue>):<fpage>e0240251</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0240251</pub-id><pub-id pub-id-type="pmid">33112857</pub-id>
</mixed-citation></ref><ref id="cit0092"><label>[92]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shirasugi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nakagawa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nishioka</surname>
<given-names>K</given-names></string-name>, et al</person-group>. <article-title>Relationship between periodontal disease and butyric acid produced by Periodontopathic Bacteria</article-title>. <source>Inflamm Regen</source>. <year>2018</year>;<volume>38</volume>(<issue>1</issue>):<fpage>23</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s41232-018-0081-x</pub-id><pub-id pub-id-type="pmid">30574217</pub-id>
</mixed-citation></ref><ref id="cit0093"><label>[93]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yonezawa</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Osaki</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hanawa</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Destructive effects of butyrate on the cell envelope of Helicobacter Pylori</article-title>. <source>J Med Microbiol</source>. <year>2012</year>;<volume>61</volume>(<issue>4</issue>):<fpage>582</fpage>&#x02013;<lpage>589</lpage>. doi: <pub-id pub-id-type="doi">10.1099/jmm.0.039040-0</pub-id><pub-id pub-id-type="pmid">22194341</pub-id>
</mixed-citation></ref><ref id="cit0094"><label>[94]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>W</given-names></string-name>, et al</person-group>. <article-title>Periodontitis-level butyrate-induced ferroptosis in periodontal ligament fibroblasts by activation of Ferritinophagy</article-title>. <source>Cell Death Discov</source>. <year>2020</year>;<volume>6</volume>(<issue>1</issue>):<fpage>119</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41420-020-00356-1</pub-id><pub-id pub-id-type="pmid">33298848</pub-id>
</mixed-citation></ref><ref id="cit0095"><label>[95]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andersen</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Ganeshkumar</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Kolenbrander</surname>
<given-names>PE</given-names></string-name></person-group>. <article-title>Helicobacter Pylori adheres selectively toFusobacteriumspp</article-title>. <source>Oral Microbiol Immunol</source>. <year>1998</year>;<volume>13</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1399-302X.1998.tb00751.x</pub-id><pub-id pub-id-type="pmid">9573823</pub-id>
</mixed-citation></ref><ref id="cit0096"><label>[96]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okuda</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kimizuka</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Katakura</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Ecological and immunopathological implications of oral bacteria in Helicobacter Pylori-infected disease</article-title>. <source>J Periodontol</source>. <year>2003</year>;<volume>74</volume>(<issue>1</issue>):<fpage>123</fpage>&#x02013;<lpage>128</lpage>. doi: <pub-id pub-id-type="doi">10.1902/jop.2003.74.1.123</pub-id><pub-id pub-id-type="pmid">12593607</pub-id>
</mixed-citation></ref><ref id="cit0097"><label>[97]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lohse</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Gulati</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>AD</given-names></string-name>, et al</person-group>. <article-title>Development and regulation of single- and multi-species Candida Albicans biofilms</article-title>. <source>Nat Rev Microbiol</source>. <year>2018</year>;<volume>16</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro.2017.107</pub-id><pub-id pub-id-type="pmid">29062072</pub-id>
</mixed-citation></ref><ref id="cit0098"><label>[98]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Janus</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Willems</surname>
<given-names>HME</given-names></string-name>, <string-name><surname>Krom</surname>
<given-names>BP</given-names></string-name></person-group>. <article-title>Candida albicans in Multispecies Oral Communities; A Keystone Commensal?</article-title>. <source>Adv Exp Med Biol</source>. <year>2016</year>;<volume>931</volume>:<fpage>13</fpage>&#x02013;<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1007/5584_2016_5</pub-id><pub-id pub-id-type="pmid">27271681</pub-id>
</mixed-citation></ref><ref id="cit0099"><label>[99]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>B</given-names></string-name>, et al</person-group>. <article-title>The cross-kingdom interaction between Helicobacter Pylori and Candida Albicans</article-title>. <source>PLOS Pathog</source>. <year>2021</year>;<volume>17</volume>(<issue>5</issue>):<fpage>e1009515</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1009515</pub-id><pub-id pub-id-type="pmid">33956895</pub-id>
</mixed-citation></ref><ref id="cit0100"><label>[100]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siavoshi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Saniee</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Vacuoles of Candida Yeast as a specialized niche for Helicobacter Pylori</article-title>. <source>World J Gastroenterol WJG</source>. <year>2014</year>;<volume>20</volume>(<issue>18</issue>):<fpage>5263</fpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v20.i18.5263</pub-id><pub-id pub-id-type="pmid">24833856</pub-id>
</mixed-citation></ref><ref id="cit0101"><label>[101]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siavoshi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Salmanian</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Kbari</surname>
<given-names>FA</given-names></string-name>, et al</person-group>. <article-title>Detection of Helicobacter Pylori-specific genes in the oral yeast</article-title>. <source>Helicobacter</source>. <year>2005</year>;<volume>10</volume>(<issue>4</issue>):<fpage>318</fpage>&#x02013;<lpage>322</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1523-5378.2005.00319.x</pub-id><pub-id pub-id-type="pmid">16104948</pub-id>
</mixed-citation></ref><ref id="cit0102"><label>[102]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000e1;nchez-Alonzo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Parra-Sep&#x000fa;lveda</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Vergara</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Detection of Helicobacter Pylori in oral yeasts from students of a Chilean university</article-title>. <source>Rev Assoc Medica Bras 1992</source>. <year>2020</year>;<volume>66</volume>(<issue>11</issue>):<fpage>1509</fpage>&#x02013;<lpage>1514</lpage>. doi: <pub-id pub-id-type="doi">10.1590/1806-9282.66.11.1509</pub-id></mixed-citation></ref><ref id="cit0103"><label>[103]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heydari</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Siavoshi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jazayeri</surname>
<given-names>MH</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori release from yeast as a vesicle-encased or free bacterium</article-title>. <source>Helicobacter</source>. <year>2020</year>;<volume>25</volume>(<issue>5</issue>):<fpage>e12725</fpage>. doi: <pub-id pub-id-type="doi">10.1111/hel.12725</pub-id><pub-id pub-id-type="pmid">32666589</pub-id>
</mixed-citation></ref><ref id="cit0104"><label>[104]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hiengrach</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Panpetch</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Chindamporn</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori, protected from antibiotics and stresses inside Candida Albicans vacuoles, cause gastritis in mice</article-title>. <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>15</issue>):<fpage>8568</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms23158568</pub-id><pub-id pub-id-type="pmid">35955701</pub-id>
</mixed-citation></ref><ref id="cit0105"><label>[105]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000e1;nchez-Alonzo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Parra-Sep&#x000fa;lveda</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Vega</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>In vitro incorporation of Helicobacter Pylori into Candida Albicans caused by acidic pH stress</article-title>. <source>Pathog Basel Switz</source>. <year>2020</year>;<volume>9</volume>(<issue>6</issue>):<fpage>489</fpage>. doi: <pub-id pub-id-type="doi">10.3390/pathogens9060489</pub-id></mixed-citation></ref><ref id="cit0106"><label>[106]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hathroubi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Servetas</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Windham</surname>
<given-names>I</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori biofilm formation and its potential role in pathogenesis</article-title>. <source>Microbiol Mol Biol Rev MMBR</source>. <year>2018</year>;<volume>82</volume>(<issue>2</issue>):<fpage>e00001</fpage>&#x02013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1128/MMBR.00001-18</pub-id><pub-id pub-id-type="pmid">29743338</pub-id>
</mixed-citation></ref><ref id="cit0107"><label>[107]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000e1;nchez-Alonzo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Arellano-Arriagada</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Castro-Seriche</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Temperatures outside the optimal range for Helicobacter Pylori increase its harboring within candida yeast cells</article-title>. <source>Biology (Basel)</source>. <year>2021</year>;<volume>10</volume>(<issue>9</issue>):<fpage>915</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biology10090915</pub-id><pub-id pub-id-type="pmid">34571792</pub-id>
</mixed-citation></ref><ref id="cit0108"><label>[108]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000e1;nchez-Alonzo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Arellano-Arriagada</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bernasconi</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title>An anaerobic environment drives the harboring of Helicobacter Pylori within candida yeast cells</article-title>. <source>Biology (Basel)</source>. <year>2022</year>;<volume>11</volume>(<issue>5</issue>):<fpage>738</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biology11050738</pub-id><pub-id pub-id-type="pmid">35625466</pub-id>
</mixed-citation></ref><ref id="cit0109"><label>[109]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000e1;nchez-Alonzo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Silva-Mieres</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Arellano-Arriagada</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Nutrient deficiency promotes the entry of Helicobacter Pylori cells into candida yeast cells</article-title>. <source>Biology (Basel)</source>. <year>2021</year>;<volume>10</volume>(<issue>5</issue>):<fpage>426</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biology10050426</pub-id><pub-id pub-id-type="pmid">34065788</pub-id>
</mixed-citation></ref><ref id="cit0110"><label>[110]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Moon</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Candida Albicans carriage in children with severe early childhood caries (S-ECC) and maternal relatedness</article-title>. <source>PLOS ONE</source>. <year>2016</year>;<volume>11</volume>(<issue>10</issue>):<fpage>e0164242</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0164242</pub-id><pub-id pub-id-type="pmid">27741258</pub-id>
</mixed-citation></ref><ref id="cit0111"><label>[111]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Alkhers</surname>
<given-names>N</given-names></string-name>, et al</person-group>. <article-title><italic toggle="yes">Candida albicans</italic> and early childhood caries: a systematic review and meta-analysis</article-title>. <source>Caries Res</source>. <year>2018</year>;<volume>52</volume>(<issue>1&#x02013;2</issue>):<fpage>102</fpage>&#x02013;<lpage>112</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000481833</pub-id><pub-id pub-id-type="pmid">29262404</pub-id>
</mixed-citation></ref><ref id="cit0112"><label>[112]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Garcia</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Acosta</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Tomar</surname>
<given-names>SL</given-names></string-name>, et al</person-group>. <article-title>Association of Candida Albicans and Cbp+Streptococcus mutans with early childhood caries recurrence</article-title>. <source>Sci Rep</source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>10802</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-90198-3</pub-id><pub-id pub-id-type="pmid">34031498</pub-id>
</mixed-citation></ref><ref id="cit0113"><label>[113]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ouyang</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Analysis of oral microbiota alterations induced by Helicobacter Pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter Pylori eradication</article-title>. <source>Helicobacter</source>. <year>2022</year>;<volume>27</volume>(<issue>5</issue>):<fpage>e12923</fpage>. doi: <pub-id pub-id-type="doi">10.1111/hel.12923</pub-id><pub-id pub-id-type="pmid">36036087</pub-id>
</mixed-citation></ref><ref id="cit0114"><label>[114]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Shao</surname>
<given-names>D</given-names></string-name>, et al</person-group>. <article-title>Oral microbiota, a potential determinant for the treatment efficacy of gastric Helicobacter Pylori eradication in humans</article-title>. <source>Pol J Microbiol</source>. <year>2022</year>;<volume>71</volume>(<issue>2</issue>):<fpage>227</fpage>. doi: <pub-id pub-id-type="doi">10.33073/pjm-2022-020</pub-id><pub-id pub-id-type="pmid">35676833</pub-id>
</mixed-citation></ref><ref id="cit0115"><label>[115]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elghannam</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Hassanien</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Ameen</surname>
<given-names>YA</given-names></string-name>, et al</person-group>. <article-title>Helicobacter pylori and oral&#x02013;gut microbiome: clinical implications</article-title>. <source>Infection</source>. <year>2024</year>;<volume>52</volume>(<issue>2</issue>):<fpage>289</fpage>&#x02013;<lpage>300</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s15010-023-02115-7</pub-id><pub-id pub-id-type="pmid">37917397</pub-id>
</mixed-citation></ref><ref id="cit0116"><label>[116]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>
<given-names>J-C</given-names></string-name>, <string-name><surname>Cw</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Cj</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>Treatment of Helicobacter Pylori infection: current status and future concepts</article-title>. <source>World J Gastroenterol</source>. <year>2014</year>;<volume>20</volume>(<issue>18</issue>):<fpage>5283</fpage>. doi: <pub-id pub-id-type="doi">10.3748/wjg.v20.i18.5283</pub-id><pub-id pub-id-type="pmid">24833858</pub-id>
</mixed-citation></ref><ref id="cit0117"><label>[117]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study</article-title>. <source>Gut</source>. <year>2024</year>;<volume>73</volume>(<issue>7</issue>):<fpage>1098</fpage>&#x02013;<lpage>1109</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2023-330883</pub-id><pub-id pub-id-type="pmid">38267200</pub-id>
</mixed-citation></ref><ref id="cit0118"><label>[118]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial</article-title>. <source>Gut</source>. <year>2024</year>;<volume>73</volume>(<issue>7</issue>):<fpage>1087</fpage>&#x02013;<lpage>1097</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2023-330168</pub-id><pub-id pub-id-type="pmid">38050061</pub-id>
</mixed-citation></ref><ref id="cit0119"><label>[119]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Katz</surname>
<given-names>PO</given-names></string-name>, <string-name><surname>Gerson</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Vela</surname>
<given-names>MF</given-names></string-name></person-group>. <article-title>Guidelines for the diagnosis and management of gastroesophageal reflux disease</article-title>. <source>Off J Am Coll Gastroenterol ACG</source>. <year>2013</year>;<volume>108</volume>(<issue>3</issue>):<fpage>308</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ajg.2012.444</pub-id></mixed-citation></ref><ref id="cit0120"><label>[120]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Jakubovics</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>B&#x000e4;chle</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Colonization of Helicobacter pylori in the oral cavity &#x02013; an endless controversy?</article-title>
<source>Crit Rev Microbiol</source>. <year>2021</year>;<volume>47</volume>(<issue>5</issue>):<fpage>612</fpage>&#x02013;<lpage>629</lpage>. doi: <pub-id pub-id-type="doi">10.1080/1040841X.2021.1907740</pub-id><pub-id pub-id-type="pmid">33899666</pub-id>
</mixed-citation></ref><ref id="cit0121"><label>[121]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>Y-T</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Bismuth drugs tackle Porphyromonas Gingivalis and attune cytokine response in human cells</article-title>. <source>Metallomics</source>. <year>2019</year>;<volume>11</volume>(<issue>7</issue>):<fpage>1207</fpage>&#x02013;<lpage>1218</lpage>. doi: <pub-id pub-id-type="doi">10.1039/c9mt00085b</pub-id><pub-id pub-id-type="pmid">31179464</pub-id>
</mixed-citation></ref><ref id="cit0122"><label>[122]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sakurai</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mori</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Okamoto</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title>Acid-inhibitory effects of vonoprazan 20 Mg compared with esomeprazole 20 Mg or rabeprazole 10 Mg in healthy adult male subjects - a randomised open-label cross-over study</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2015</year>;<volume>42</volume>(<issue>6</issue>):<fpage>719</fpage>&#x02013;<lpage>730</lpage>. doi: <pub-id pub-id-type="doi">10.1111/apt.13325</pub-id><pub-id pub-id-type="pmid">26193978</pub-id>
</mixed-citation></ref><ref id="cit0123"><label>[123]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Suzuki</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gotoda</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Kusano</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter Pylori treatment: a multicentre randomised trial in Japan</article-title>. <source>Gut</source>. <year>2020</year>;<volume>69</volume>(<issue>6</issue>):<fpage>1019</fpage>&#x02013;<lpage>1026</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2019-319954</pub-id><pub-id pub-id-type="pmid">31915235</pub-id>
</mixed-citation></ref><ref id="cit0124"><label>[124]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheung</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Lyu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>Z</given-names></string-name>, et al</person-group>. <article-title>Vonoprazan dual or triple therapy versus bismuth-quadruple therapy as first-line therapy for Helicobacter Pylori infection: a three-arm, randomized clinical trial</article-title>. <source>Helicobacter</source>. <year>2024</year>;<volume>29</volume>(<issue>5</issue>):<fpage>e13133</fpage>. doi: <pub-id pub-id-type="doi">10.1111/hel.13133</pub-id><pub-id pub-id-type="pmid">39244723</pub-id>
</mixed-citation></ref><ref id="cit0125"><label>[125]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chey</surname>
<given-names>WD</given-names></string-name>, <string-name><surname>M&#x000e9;graud</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Laine</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Vonoprazan triple and dual therapy for Helicobacter Pylori infection in the United States and Europe: randomized clinical trial</article-title>. <source>Gastroenterology</source>. <year>2022</year>;<volume>163</volume>(<issue>3</issue>):<fpage>608</fpage>&#x02013;<lpage>619</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.gastro.2022.05.055</pub-id><pub-id pub-id-type="pmid">35679950</pub-id>
</mixed-citation></ref><ref id="cit0126"><label>[126]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Qu</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>The impact of Helicobacter Pylori eradication with vonoprazan-amoxicillin dual therapy combined with probiotics on oral microbiota: a randomized double-blind placebo-controlled trial</article-title>. <source>Front Microbiol</source>. <year>2023</year>;<volume>14</volume>:<fpage>1273709</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2023.1273709</pub-id><pub-id pub-id-type="pmid">37849923</pub-id>
</mixed-citation></ref><ref id="cit0127"><label>[127]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kopra</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lahdentausta</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pieti&#x000e4;inen</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Systemic antibiotics influence periodontal parameters and oral microbiota, but not serological markers</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2021</year>;<volume>11</volume>:<fpage>774665</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2021.774665</pub-id><pub-id pub-id-type="pmid">35004349</pub-id>
</mixed-citation></ref><ref id="cit0128"><label>[128]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arredondo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Blanc</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mor</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Tetracycline and multidrug resistance in the oral microbiota: differences between healthy subjects and patients with periodontitis in Spain</article-title>. <source>J Oral Microbiol</source>. <year>2020</year>;<volume>13</volume>(<issue>1</issue>):<fpage>1847431</fpage>. doi: <pub-id pub-id-type="doi">10.1080/20002297.2020.1847431</pub-id><pub-id pub-id-type="pmid">33391624</pub-id>
</mixed-citation></ref><ref id="cit0129"><label>[129]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anderson</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>von Ohle</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Frese</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>The oral microbiota is a reservoir for antimicrobial resistance: resistome and phenotypic resistance characteristics of oral biofilm in health, caries, and periodontitis</article-title>. <source>Ann Clin Microbiol Antimicrob</source>. <year>2023</year>;<volume>22</volume>(<issue>1</issue>):<fpage>37</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12941-023-00585-z</pub-id><pub-id pub-id-type="pmid">37179329</pub-id>
</mixed-citation></ref><ref id="cit0130"><label>[130]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yuan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title>Systemic antibiotics increase microbiota pathogenicity and oral bone loss</article-title>. <source>Int J Oral Sci</source>. <year>2023</year>;<volume>15</volume>(<issue>1</issue>):<fpage>4</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41368-022-00212-1</pub-id><pub-id pub-id-type="pmid">36631439</pub-id>
</mixed-citation></ref><ref id="cit0131"><label>[131]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Zou</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Xiang</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Helicobacter Pylori infection is associated with the Co&#x02010;occurrence of bacteria in the oral cavity and the gastric mucosa</article-title>. <source>Helicobacter</source>. <year>2021</year>;<volume>26</volume>(<issue>2</issue>):<fpage>e12786</fpage>. doi: <pub-id pub-id-type="doi">10.1111/hel.12786</pub-id><pub-id pub-id-type="pmid">33596339</pub-id>
</mixed-citation></ref><ref id="cit0132"><label>[132]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Helicobacter Pylori infection and eradication: exploring their impacts on the gastrointestinal microbiota</article-title>. <source>Helicobacter</source>. <year>2020</year>;<volume>25</volume>(<issue>6</issue>):<fpage>e12754</fpage>. doi: <pub-id pub-id-type="doi">10.1111/hel.12754</pub-id><pub-id pub-id-type="pmid">32876377</pub-id>
</mixed-citation></ref></ref-list></back></article>